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ABSTRACT
Nectin-1 is Degraded in Chlamydia trachomatis-infected Genital Epithelial Cells and is
Required for Herpes Simplex Virus Co-infection-induced C.trachomatis Persistence

By
Jingru Sun
The obligate intracellular bacterium Chlamydia trachomatis is the most common
bacterial STD agent in the US. This bacterium has a unique biphasic developmental cycle
in which the infectious elementary body (EB) infects a host mucosal epithelial cell and
differentiates into the replicative form (the reticulate body or RB) within a modified
vacuole called an inclusion. The RB later divides and develops back into an EB and is
released, perpetuating the infectious cycle. When developing chlamydiae are exposed to
unfavorable environmental conditions, they deviate from the normal developmental cycle
into a non-infectious but viable state termed persistence. Previous data from our
laboratory indicate that i) during C. trachomatis/HSV co-infection, the chlamydiae
become persistent and ii) HSV gD interaction with host cell surface is sufficient to induce
this response. During viral entry, HSV gD interacts with one of four host co-receptors,
one of which is the host adhesion molecule nectin-1. Interestingly, Western blotting
demonstrated that nectin-1 is significantly decreased in C. trachomatis-infected HeLa
cells. Additional studies indicated that active C. trachomatis replication is required for
nectin-1 down-regulation and nectin-1 is likely down-regulated post-translationally.
CPAF, a chlamydia-secreted protease, is responsible for degrading several host proteins.
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Both in vivo experiments using CPAF-specific chemical inhibitors and cell-free cleavage
assays using recombinant CPAF indicate that nectin-1 is degraded by CPAF in C.
trachomatis-infected cells. Further studies suggest that nectin-1 is the most likely
candidate involved in triggering HSV-induced chlamydial persistence. Co-infection
experiments using nectin-1-specific HSV-1 mutants suggest that nectin-1 is, indeed,
required for persistence induction. Additional studies in single co-receptor-expressing
CHO cells demonstrate that, despite the fact that HSV-1 enters both HVEM- and nectin1-expressing cells, viral co-infection reduces chlamydial infectivity only in the CHOnectin-1 cell line. These data confirm that HSV/nectin-1 interaction is sufficient for
chlamydial persistence induction. Although nectin-1 ligation is known to activate Cdc42,
pull-down assays indicate that Cdc42 is not activated in co-infected HeLa cells. Taken
together, these data suggest that: i) HSV gD-nectin-1 binding activates a novel host
epithelial cell pathway that restricts chlamydial development and ii) the chlamydiae may
degrade nectin-1 to evade this inhibitory host response.
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CHAPTER 1
INTRODUCTION
Chlamydia trachomatis
Members of the genus Chlamydia are the etiologic agents of several important
human diseases. The species Chlamydia pneumoniae is a widespread respiratory tract
pathogen that primarily causes community-acquired pneumonia. According to reports
from the Centers for Disease Control and Prevention (CDC), in the Unites States,
approximately 50% of young adults and 75% of elderly persons have serological
evidence of previous C. pneumoniae infection (CDC, 2005). It is estimated that 300,000
cases of C. pneumoniae pneumonia occur each year. Recently, seroepidemiological
studies have indicated a possible association between chronic C. pneumoniae infection
and cardiovascular disease (Kuo et al., 1993; Saikku et al., 1988) as well as late-onset
Alzheimer’s disease (Balin et al., 1998). In addition, there is evidence linking unresolved
respiratory C. pneumoniae infection with asthma (Hahn et al., 1991) and chronic
obstructive pulmonary disease (Blasi et al., 1993). The species Chlamydia psittaci, a
zoonotic pathogen common in birds, causes psittacosis in humans. Although the illness
caused by psittacosis is usually mild to moderate in severity, it can be life threatening if
not properly diagnosed and treated (Kirchner, 1997).
The third major human species of genus Chlamydia is Chlamydia trachomatis,
which includes two biovars: the Lymphogranuloma Venereum (LGV) biovar and the
trachoma biovar. The LGV biovar is subdivided into 4 serovars: L1, L2, L2a, and L3.
They primarily affect lymphatic tissue after invasion through an epithelial surface,
causing an invasive sexually transmitted disease. LGV infections usually present with
genital ulcers, papules, or inguinal lymphadenopathy (buboes) (Mabey & Peeling, 2002).
The trachoma biovar is subdivided into 14 serovars (A-K, Ba, Da, and Ia), based on
antiserum specificity to the variable region of the major outer membrane protein
(MOMP). Serovars A, B, Ba, and C are the causative agents of trachoma, the world’s
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leading cause of infectious blindness (Thylefors et al., 1995). It is estimated that active
trachoma affects approximately 84 million people, causing an estimated loss of $2.9
billion in productivity annually (Kumaresan & Mecaskey, 2003), and that about 1.3
million people are blinded by these bacteria (Wright et al., 2008). Serovars D-K are
considered the most common sexually transmitted bacterial pathogens worldwide
(Gerbase et al., 1998), with an estimated 4 million new cases each year in the United
States. Initial C. trachomatis genital tract infections are often asymptomatic, which
allows the bacteria to ascend the genital tract undetected, and thus untreated. Eventually,
this will lead to severe complications, including epididymitis and prostatitis in men as
well as salpingitis, endometritis, pelvic inflammatory disease, ectopic pregnancy and
infertility in women (Darville, 2000a). Infections by C. trachomatis serovars D to K also
cause neonatal conjunctivitis (Schachter et al., 1986) and pneumonia (Beem & Saxon,
1977) by vertical transmission through an infected birth canal.
The Chlamydial Developmental Cycle
All chlamydiae are Gram-negative obligate intracellular bacteria and share a
unique biphasic developmental cycle (Fig. 1.1). C. trachomatis alternates between two
morphologically distinct forms. First, the extracellular, infectious but metabolically inert
form (the elementary body or EB, 0.3µm diameter) attaches to and enters mucosal
epithelial cells via receptor mediated endocytosis (Wyrick, 2000). EBs are characterized
by a highly compacted nucleoid due to the condensation by the chlamydial histone-like
proteins HctA and HctB (Barry et al., 1992; Brickman et al., 1993). EBs have little or no
peptidoglycan in their cell walls (Ghuysen & Goffin, 1999). Instead, structural rigidity is
provided by the highly cross-linked outer-membrane complex. Several chlamydial
ligands (such as MOMP, heat shock protein 70, the outer membrane complex protein
OmcB, and heparan sulfate-like glycosaminoclycans) and host cell receptors (such as the
heperan sulfate receptor, the mannose and mannose-6-phosphate receptors, and the
estrogen receptor) have been proposed to be involved in attachment and entry of
chlamydiae (Chen & Stephens, 1997; Davis & Wyrick, 1997; Davis et al., 2002;
Raulston et al., 2002; Stephens et al., 2000; Stephens et al., 2001; Su et al., 1996; Wyrick,
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2000; Zhang & Stephens, 1992). After entry, EB-containing endosomes avoid fusion with
host cell lysosomes, intercept sphingomyelin and cholesterol from the exocytic pathway
and are rapidly trafficked to the perinuclear region of the host cell (Hackstadt et al., 1996;
Wolf & Hackstadt, 2001). Following these actions, EBs differentiate into larger (1µm
diameter), metabolically active but non-infectious reticulate bodies (RBs) within an
enlarged endosomal sac, termed an inclusion. The mature chlamydial inclusion is
established by insertion of multiple chlamydial proteins and host cell-acquired lipids,
suggesting chlamydiae actively modify the inclusion and manipulate the host cell to
provide a protected intracellular niche (Hackstadt et al., 1996; Hackstadt et al., 1997;
Wylie et al., 1997). Using ATP and metabolites from the host cell, RBs grow and divide
by binary fission. After 8-12 rounds of replication, the RBs mature into infectious EBs,
which are released from the host cell (Wyrick, 2000).

Figure 1.1 The Chlamydia trachomatis developmental cycle. (Courtesy Jennifer Vanover)
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Chlamydial Persistence
The normal chlamydial developmental cycle can be interrupted when developing
chlamydiae are exposed to unfavorable environmental factors (Beatty et al., 1994a;
Darville, 2000a; Gerard et al., 2001; Raulston, 1997). In this situation, the chlamydiae
deviate from the normal developmental cycle into a state termed persistence (Hogan et al.,
2004) and can remain in this state for weeks or months (Galasso & Manire, 1961).
Although chlamydial persistence in vivo has been difficult to demonstrate, recent studies
strongly suggest that chlamydiae do become persistent in humans (Dean et al., 2000;
Fortenberry et al., 1999; Gerard et al., 2001; Gerard et al., 2002; Patton et al., 1994).
Development of persistence is thought to be a mechanism used by the chlamydiae to
ensure survival under stressful conditions of growth and development (Harper et al., 2000;
Mpiga & Ravaoarinoro, 2006).
Persistent chlamydiae have been traditionally described as a viable but culturenegative form of chlamydiae (Beatty et al., 1994b) (Fig. 1.2). During the persistent state,
chlamydiae continue to synthesize unprocessed 16S rRNA and replicate chromosomes
(Gerard et al., 1998; Gerard et al., 2001). The RBs continue to enlarge but neither
undergo binary fission nor differentiate back into EBs, thus resulting in enlarged RBs and
decreased EB infectivity (Beatty et al., 1993; Beatty et al., 1994a). At the ultrastructural
level, persistent chlamydiae appear as swollen, misshapen, diffuse RBs. Inclusions
containing persistent chlamydiae often contain large numbers of membrane blebs. In
addition, it is reported that, during persistent state, accumulation of MOMP is decreased
while the accumulation of the immunodestructive antigen HSP60 is stable or increased
(Beatty et al., 1993; Beatty et al., 1994b). Finally, because they are still viable, persistent
chlamydiae have ability to re-enter and complete the normal developmental cycle once
the persistence “inducer” is removed.
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Normal chlamydiae

Persistent chlamydiae
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Figure 1.2 Transmission electron microscopy (TEM) pictures of normal and persistent
chlamydiae.

Since chlamydial persistence represents a long-term relationship between the
chlamydiae and their host cells, there has been a great amount of interest within the field
to further define this phenomenon. So far, several different factors have been discovered
to induce chlamydial persistence in vitro, including interferon-γ (IFN-γ), tumor necrosis
factor-α (TNF-α), or penicillin G exposure as well as amino acid, iron, or glucose
deprivation. Persistence has also been reported to develop following phage infection of
chlamydiae (Hsia et al., 2000) or chlamydial infection of monocytes (Koehler et al.,
1997). Spontaneous development of chlamydial persistence has also been found to occur
in continuous cultures without presence of any stresses (Shatkin et al., 1985).
Propagation of chlamydiae in host cells deprived of amino acids, glucose, or iron
has been shown to induce persistence. Under iron restriction, the inclusions of C.
trachomatis serovar E are small and surrounded by electron-dense material (Raulston,
1997). The RBs within these inclusions become abnormal with loose and wavy outer
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membranes (Raulston, 1997). Minor reductions in amino acids or glucose concentration
in culture media also induce persistence (Coles et al., 1993; Harper et al., 2000). In all
cases where nutrient restriction has been used to induce persistence, the chlamydiae reenter the normal developmental cycle following supplementation with the appropriate
nutrients (Coles et al., 1993; Harper et al., 2000; Raulston, 1997).
Of the cytokine-induced persistence models, IFN-γ-induced persistence has been
best characterized. For example, infection of HeLa cells with C. trachomatis serovar A
followed by exposure to 0.2 µg/ml IFN-γ produces small chlamydial inclusions
containing enlarged and abnormal RBs (Beatty et al., 1993). The mechanism behind this
phenomenon is that IFN-γ exposure increases host cell indoleamine 2,3-dioxygenase
(IDO) expression, leading to the conversion of tryptophan to N-formylkynurenine. The
resultant tryptophan deficiency drives the developing chlamydiae into the persistent state.
Removal of IFN-γ from the culture media or addition of tryptophan to the culture media
allows the persistent chlamydiae to recover and resume normal growth (Beatty et al.,
1993; Byrne et al., 1986). In murine cells, IFN-γ exposure induces chlamydial persistence
via a different mechanism. IFN-γ activates the p47 GPTase, Iigp1, which inhibits
chlamydial development by restricting vesicular trafficking to the developing inclusions
(Nelson et al., 2005).
Finally, many researchers have also observed that exposure of chlamydia-infected
cells to antibiotics, such as penicillin, ofloxacin, or ciprofloxacin, induces development of
greatly enlarged and aberrant RBs (Dreses-Werringloer et al., 2000; Johnson & Hobson,
1977; Segreti et al., 1992). The RBs resume normal growth after removal of antibiotics.
Generally, agents that target chlamydial RNA or protein synthesis inhibit chlamydial
differentiation from EB to RB or from RB to EB, while those that target DNA or
peptidoglycan synthesis inhibit only RB to EB differentiation (Moulder, 1991). These
observations indicate that inappropriate antimicrobial therapy may be a significant cause
of persistent chlamydial infection in vivo.
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Chlamydia Protease-like Activity Factor (CPAF)
The unique, biphasic chlamydial developmental cycle involves a complex
interaction between the pathogen and its obligate host. To ensure their successful
intracellular replication and long-term survival within infected host cells, chlamydiae
have evolved various strategies to evade host defense systems and to modulate host cell
functions. For example, during chlamydial infection, chlamydiae prevent productively
and persistently infected host cells from undergoing apoptosis, which may allow them to
maintain long-term survival within infected cells (Dean & Powers, 2001; Dong et al.,
2005a; Fan et al., 1998; Fischer et al., 2004; Geng et al., 2000; Pirbhai et al., 2006;
Rajalingam et al., 2001). Chlamydiae alter host cell-cell contacts to facilitate chlamydial
growth (Prozialeck et al., 2002). Chlamydiae can also modify host cell cytoskeletal
arrangement and signal transduction to benefit chlamydial intravacuolar replication
(Clausen et al., 1997; Majeed & Kihlstrom, 1991; Majeed et al., 1993; Schramm &
Wyrick, 1995; Xia et al., 2003).
Another strategy that chlamydiae use to survive in their intracellular habitat is the
secretion of chlamydia protease-like activity factor (CPAF). CPAF is synthesized within
the chlamydial inclusion and subsequently secreted into the host cell cytoplasm (Fan et
al., 2002; Zhong et al., 2001). CPAF has been shown to be produced by the two human
pathogens C. trachomatis and C. pneumoniae as well as by the three non-human
pathogens, C. muridarum, C. psittaci and C. caviae (Dong et al., 2005b; Fan et al., 2002;
Zhong et al., 2001). Further studies demonstrated that there is little or no difference in
CPAF expression between persistent and productive chlamydial infections, suggesting
that CPAF production may be important in both types of infection (Heuer et al., 2003;
Shaw et al., 2002). CPAF is encoded by a single open reading frame (ORF) in the
chlamydial genome, but the main purified product consists of two fragments. CPAF is
initially produced as an inactive proenzyme of 70 kDa and rapidly processed into two
fragments, a 35 kDa C-terminal portion (designated CPAFc) and a 29 kDa N-terminal
portion (designated CPAFn), which must form intramolecular dimers to acquire
proteolytic activity (Dong et al., 2004a; Dong et al., 2004b). Studies by Dong et al
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further confirmed that cleavage of CPAF is both necessary and sufficient for CPAF
activity (Dong et al., 2004a). The proteolytic activity of CPAF is inhibited by the
cytosolic proteasome inhibitor lactacystin but not by other proteasome inhibitors such as
MG132 and MG115, or by broad spectrum protease inhibitors, such as PMSF and
pepstatin A (Zhong et al., 2000; Zhong et al., 2001).
A number of studies suggest that CPAF plays important roles in promoting
chlamydial replication and protecting infected cells from host immune detection. For
example, CPAF has been shown to cleave RFX5 and USF-1, two eukaryotic transcription
factors required for both major histocompatibility complex (MHC) class I and II antigen
expression (Zhong et al., 1999; Zhong et al., 2000). This process may help infected cells
escape immune detection so that the chlamydiae have sufficient time to complete their
replication in infected hosts. Similarly, CPAF has been found to be responsible for
degrading keratin-8 (Dong et al., 2004c), pro-apoptotic BH-3 only proteins (Pirbhai et al.,
2006), and CD1d glycoprotein (Kawana et al., 2007). Keratin-8 is a key subunit of
intermediate filaments in epithelial cells. Cleavage of keratin-8 would increase the
solubility of the host cell cytoskeleton, thus facilitating the expansion of chlamydia-laden
inclusion, which is essential for chlamydial intracellular replication. Pro-apoptotic BH-3
only proteins are required for apoptosis induction in response to cytotoxic stimuli or
exogenous stress, and they function by neutralizing their pro-survival counterparts or
activating pro-apoptotic Bcl-2 family members Bax and Bak (Bouillet & Strasser, 2002).
Down-regulation of BH-3 only proteins contributes to chlamydial anti-apoptotic activity
which may help chlamydiae evade CTL-mediated host cell apoptosis induction and, thus,
benefit chlamyidal long-term survival within infected host cells (Pirbhai et al., 2006).
CD1d glycoprotein is an MHC-like protein that presents lipid antigens to natural killer T
cells. Degradation of CD1d protein may prevent recognition or elimination of chlamydiae
from the host innate immune system (Kawana et al., 2007). Taken together, CPAF, the
first example of a cytoplasmically localized chlamyidal protease, seems to execute its
functions by degrading host cell proteins to either facilitate chlamydial intravacuolar
replication or help chlamydiae evade host immune surveillance.
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Nectins
In epithelial cells, intercellular adhesions are intimately involved in maintaining
cell structure, transmitting information, regulating cellular migration, and imparting
strength and rigidity to tissues (Farquhar & Palade, 1963; Gumbiner, 1996; Takeichi,
1995). Intercellular adhesions are mainly maintained by cell-cell adherens junctions (AJs)
and tight junctions (TJs) (Farquhar & Palade, 1963). Importantly, the organization and
functions of TJs are dependent on the formation and maintenance of AJs (Tsukita &
Furuse, 1999). TJs are formed at the apical side of AJs and regulate selective diffusion of
solutes and water along the paracellular pathway. Thus, TJs act as a fence between the
apical and basolateral plasma membrane domains in epithelial cells (Tsukita et al., 1999;
Tsukita et al., 2001). At TJs, three cell adhesion molecules (CAMs) {claudin, occludin,
and junctional adhesion molecule (JAM)} have been identified, and they are linked to the
actin cytoskeleton through peripheral membrane proteins such as ZO-1, -2 and -3
(Tsukita et al., 2001). AJs are located immediately at the basal side of TJs and connect
the lateral surfaces of adjacent epithelia cells. AJs form complexes with actin and myosin
filaments to internally brace cells and thereby control their shape. AJs play important
roles not only in the formation and maintenance of TJs, but also in concentrating
biologically active molecules such as cell surface receptors, signaling molecules, and
oncoproteins (Gumbiner, 2000; Nagafuchi, 2001; Perez-Moreno et al., 2003; Tsukita et
al., 1992; Van Aelst & Symons, 2002). E-cadherin, an important component of AJs, is a
Ca2+-dependent cell-cell adhesion molecule found in epithelial cells (Takeichi, 1991). Ecadherin is a member of the cadherin superfamily, which consists of more than 80
members. Most cadherins are single-membrane-spanning molecules and are associated
with the actin cytoskeleton through peripheral membrane proteins, including α- and βcatenins, vinculin, and α-actinin (Gumbiner, 2000; Nagafuchi, 2001; Takeichi, 1995). It
was previously believed that AJs were formed by cadherins, but recent evidence indicates
that AJs are formed by both cadherins and nectins (Irie et al., 2004; Nakanishi & Takai,
2004; Ogita & Takai, 2006a; Sakisaka & Takai, 2004; Shimizu & Takai, 2003; Takai et
al., 2003; Takai & Nakanishi, 2003; Takeichi, 1991).
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Nectins are Ca2+-independent, immunoglobulin (Ig)-like cell-cell adhesion
molecules with three extracellular Ig-like loops, a single transmembrane region (except
for nectin-1γ) and a cytoplasmic tail. The nectin family currently contains at least 4
members (nectins-1~4) (Sakisaka & Takai, 2004; Takai & Nakanishi, 2003). Nectin-1,
nectin-2 and nectin-3 are widely distributed in a variety of tissues and cell types, such as
epithelial cells, neurons, and fibroblasts (Takai & Nakanishi, 2003). Nectin-2 and nectin3 are also found in blood cells and spermatids, where cadherins are not expressed
(Bouchard et al., 2000; Lopez et al., 1998; Ozaki-Kuroda et al., 2002). Human nectin-4
appears to be primarily distributed in placenta (Reymond et al., 2001). Each nectin first
forms cis-dimers homophilically and then the cis-dimers homophilically or
heterophilically interact in trans with each other to form trans-dimers. The
heterophilically formed trans-interactions are stronger than the homophilically formed
trans-interactions (Sakisaka & Takai, 2004). In contrast, cadherins only can form
homophilic trans-dimers (Takeichi, 1995). In addition to interacting with each other,
nectins also interact in trans with other Ig-like molecules such as nectin-like molecules
(Necls), CD226/DNAM-1, and CD96/Tactile (Bottino et al., 2003; Ikeda et al., 2003;
Kakunaga et al., 2005; Seth et al., 2007; Shingai et al., 2003). The cytoplasmic tail of
each nectin member binds to afadin, an actin filament (F-actin)-binding protein, which
connects nectin to the actin cytoskeleton (Takai & Nakanishi, 2003). Afadin has multiple
domains and acts as an adaptor protein by binding many scaffolding proteins and F-actinbinding proteins, associating nectins with other cell-cell adhesion and intracellular
signaling pathways (Takai et al., 2008). This novel nectin-afadin adhesion system is
required not only for the formation of AJs but also for the subsequent formation of TJs,
as well as for the formation of functional cell-cell junctions, acting cooperatively with or
independently of cadherins (Takai & Nakanishi, 2003). Additionally, this nectin-afadin
adhesion system has been shown to be novel mediator of many other cellular events
including movement, proliferation, differentiation, polarization, and the entry of viruses
by interacting with other CAMs and cell surface receptors. For example, transinteractions of nectins induce the activation of c-Src. The activated c-Src stimulates the
small G proteins Cdc42 and Rac, which are eventually involved in cell-cell adhesion
through reorganization of the actin cytoskeleton, gene expression by activation of the
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JNK pathway, and cell polarization by cell polarity proteins (Honda et al., 2003;
Kawakatsu et al., 2002). Furthermore, this adhesion system regulates the formation of
synapses in neurons and the organization of heterotypic junctions between Sertoli cells
and spermatids in the testis (Bouchard et al., 2000; Mizoguchi et al., 2002; Ozaki-Kuroda
et al., 2002).
The functions of nectin-1 and nectin-2 in mediating the entry of viruses into host
cells have been extensively studied. The cDNAs of nectin-1 and nectin-2 were originally
described as encoding poliovirus-receptor-related proteins, and, therefore were named
PRR-1 and PRR-2 (Eberle et al., 1995; Lopez et al., 1995). However, neither PRR-1 nor
PRR-2 has been shown to serve as a poliovirus receptor. Because they were later
demonstrated to serve as receptors for α-herpes viruses, they were renamed HveC and
HveB, respectively (Geraghty et al., 1998; Warner et al., 1998). Finally, they were
renamed nectin-1 and nectin-2, respectively, due to their roles in cell-cell adhesion.
Nectin-1 and nectin-2 have different affinity specificities for wild-type
alphaherpesviruses. Nectin-1 mediates entry of all α-herpes viruses tested so far,
including herpes simplex virus type I (HSV-1) and type 2 (HSV-2), as well as
pseudorabies virus (Campadelli-Fiume et al., 2000; Spear et al., 2000). In contrast,
nectin-2 primarily mediates the entry of HSV-2 into host mucosal epithelial cells
(Campadelli-Fiume et al., 2000; Spear et al., 2000). It remains unknown whether nectin-3
and nectin-4 serve as receptors for viruses.
Herpes Simplex Virus (HSV)
HSV-1 and HSV-2 are members of the viral family Herpesviridae and cause a
range of infections from mild uncomplicated mucocutaneous infection to life threatening
disease such as meningitis. Although both HSV-1 and HSV-2 can infect either oral or
genital sites, HSV-1 is more often associated with oral infections such as cold sores or
fever blisters, while HSV-2 is considered the primary etiological agent of genital herpes.
HSV can infect many cell types, but the two most important cellular targets are
mucosal/skin epithelial cells and neurons. After primary infection of epithelial cells, the
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virus establishes latent infection within sensory and autonomic neurons whose axons
extend to the locale of the lesions. Latent infection can be periodically reactivated in
response to many stimuli such as colds and influenza, emotional and physical stress,
immune suppression, exposure to bright sunlight, gastric upset, fatigue, or injury.
Reactivated virus transports, via the nerve’s axon, back to the site of original infection to
cause recurrent lesions. Most people suffer an average of 5 reactivations per year, during
which lesions and virions are present (Corey et al., 1983). Evidence also suggests that
HSV-2 is commonly shed in the absence of detectable symptoms (Mertz et al., 1992).
The HSV virion has a large double-stranded DNA genome about 150 kbp. The
genome is packed within a capsid, an icosahedral protein cage, containing 162 capsomers
or morphological elements (Spear, 2004). The capsid is in turn coated with a protein layer
(the tegument) and, subsequently, an envelope composed of lipids and more than a dozen
viral proteins and glycoproteins. Several envelope glycoproteins are essential for viral
entry (Spear, 2004). HSV-1 and HSV-2 each contain at least 74 genes within their
genomes, encoding proteins involved in forming the viral capsid, tegument and envelope,
as well as controlling the replication and infectivity of the virus (Dolan et al., 1998).
Entry of HSV (Fig. 1.3A) into host cells is initiated when the virion binds to the
cell surface receptor heparan sulfate using the viral envelope proteins gC and/or gB (to a
lesser extent). Although this binding of gC or gB with heparan sulfate significantly
increases the efficiency of HSV infection, it is not absolutely essential (Spear, 2004).
After initial binding, the viral gD envelope glycoprotein interacts with one of 4 cellular
co-receptors including HVEM (herpes virus entry mediator), nectin-1, nectin-2, or 3-O
sulfated heparan sulfate (3-O-S-HS) (Spear, 2004). HVEM is a member of the tumor
necrosis factor (TNF) receptor family which is present on B and T lymphoctyes, other
leucocytes, fibroblasts, and epithelial cells, but not on neurons (Hsu et al., 1997; Kwon et
al., 1997; Marsters et al., 1997; Montgomery et al., 1996). HVEM can be used as a coreceptor by both HSV-1 and HSV-2 with equally high efficiency (Spear, 2004). Nectin-1
and nectin-2, as described in the nectins section, are two cell adhesion molecules
belonging to the immunoglobulin superfamily which are expressed on fibroblasts,
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neurons, and epithelial cells. Nectin-1 mediates entry of both HSV-1 and HSV-2, while
nectin-2 primarily mediates entry of HSV-2 (Spear, 2004). 3-O-S-HS is wildly
distributed on human cells and primarily mediates HSV-1 entry (Spear, 2004). Binding of
gD to any one of the these co-receptors facilitates the fusion of viral envelope with the
host cell plasma membrane. Viral envelope-membrane fusion also requires assistance
from viral gB and gH/gL proteins (Spear et al., 2000; Spear, 2004). HSV was previously
believed to enter cells only via envelope-membrane fusion, but recently it has been
reported that HSV entry can also occur through direct penetration of the cell plasma
membrane or by endocytic pathways, depending on the host cell line used.
After fusion occurs, the virus releases the capsid-tegument structure into the
cytoplasm (Fig. 1.3B). Subsequently, the capsid is transported to the host nucleus where
the viral DNA genome circularizes and is transcribed. Immediate early genes (or α-genes)
are first transcribed which are involved in transcriptional regulation and are not found in
the mature virion. They also promote transcription of early genes (or β-genes). Early
proteins include DNA polymerase and enzymes, which are mainly involved in DNA
replication. Late genes (or γ-genes), transcribed after DNA synthesis, are translated in the
cytoplasm and then transported back to the nucleus. Viral envelope glycoproteins are
synthesized in the rough endoplasmic reticulum where they obtain high mannose sugar
chains. They are then processed by the host secretory pathway and localized to the
nuclear and cytoplasmic membranes, where they are surface exposed. New virions are
assembled in the nucleus, bud through the nuclear membrane via areas in which the viral
envelope glycoproteins are enriched, and egress the host cell by vesicular transport
(Roizman, 2001b).
Numerous studies have demonstrated that HSV infection can modulate host cell
signal transduction pathways. Yokota et al has reported that during the early stage (2 to 3
hour post infection) of HSV-1 infection in human amnion FL cells, the IFN signal
pathway is suppressed by inhibiting IFN-induced phosphorylation of STATs and Janus
kinases (Yokota et al., 2001). In HSV-infected T cells, T cell receptor (TCR) signal
transduction is suppressed by inhibition of the activation of LAT (linker for activation of
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T cells) and the steps distal to LAT in the TCR signal cascade, including inhibition of
calcium flux and multiple MAPK (Sloan et al., 2006). In human monocyte cell lines,
interaction of gD with HVEM is involved in NF-κB-dependent protection against
apoptosis (Sciortino et al., 2008; Teresa Sciortino et al., 2007). HSV infection also
induces the expression of host cellular suppressor of cytokine signaling-3 (SOCS3), a
negative regulator of the JAK/STAT pathway (Yokota et al., 2005), conferring efficient
viral replication. Additionally, Hoppe et al have demonstrated that the small Rho-like
GTPases Rac1 and Cdc42 are activated at 15 to 30 minutes after HSV-1 infection of
epithelial MDCK canine kidney cells (Hoppe et al., 2006). Inhibition of Cdc42 activity
using a dominant-negative inhibitor decreased both Cdc42 activation and subsequent
viral replication. Since Rac1 and Cdc42 are members of the nectin-1 trans-interaction
induced signaling pathway, it is speculated that HSV-1/nectin-1 interaction is responsible
for activation of Rac1 and Cdc42 (Hoppe et al., 2006).
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Figure 1.3 Replication cycle of HSV. A. Attachment and entry of HSV virions into the
host cell. B. Replication and release of HSV from the host cell.
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HSV and C. trachomatis Co-infection
Despite substantial improvement in the prevention of sexually transmitted
diseases (STDs), they still represent a substantial fraction of the disease burden.
According to reports from the CDC, STDs are among the most common infections in the
United States. Approximately 19 million new cases of STDs occur each year in the
United States, almost half of them among people ages 15 to 24 (CDC, 2006; Weinstock
et al., 2004). In addition to the health consequences of STDs, these diseases also cause a
severe economic burden. The direct medical costs of treating these diseases were
estimated at up to 14.7 billion dollars in the United States in 2006 (CDC, 2006).
Moreover, epidemiological studies have demonstrated that infection with one STD
increases the chance for individuals to acquire others (Cameron et al., 1989; Laga et al.,
1993; Plummer et al., 1991). For instance, HSV-2 infection increases the risk for
acquiring Human Immunodeficiency Virus (HIV) infection by 3-fold (Freeman et al.,
2007).
In the United States, two of the most common STD agents are C. trachomatis
(serovars D-K), causing 4 million new infectious diseases annually and HSV (primarily
HSV-2), causing 200,000-500,000 new infectious cases annually (Johnson et al., 1989).
A number of studies have shown that C. trachomatis and HSV-2 co-infections occur in
vivo. Both pathogens have been simultaneously isolated from the genital tract of women
afflicted with endometritis and salpingitis (Paavonen et al., 1985) or cystitis (Tait et al.,
1985). Serological studies indicate that HSV-2 positive individuals are likely to be C.
trachomatis-positive as well (Paroli et al., 1990; Silins et al., 2002; Vetter et al., 1990).
In addition, seropositivity rates of > 50% for both HSV-2 and C. trachomatis have been
reported, implying that some participants had been exposed to both pathogens (Duncan et
al., 1992; Wagner et al., 1994). Although IgG seropositivity can not be used to establish
concurrent infection, it is likely that both organisms were present simultaneously in the
genital tracts of some individuals, since C. trachomatis often causes long-term infections
and HSV-2 reactivates on average 5 times per year.
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Several groups have also established HSV/C. trachomatis co-infection in cell
culture. Chiarini et al demonstrated that the number of cells positive for chlamydiae by
immunofluorescence was reduced when HeLa cells were co-infected with HSV-2/C.
trachomatis serovar D (Chiarini et al., 1996). Pontefract et al observed that Vero cells coinfected with C. trachomatis serovar L2 and HSV-2 contained swollen inclusions with
few RBs or EBs (Pontefract et al., 1989). HSV-2 pre-infection of HT-1376 human
bladder cells reduced production of infectious C. trachomatis EBs by about 15-fold
(Superti et al., 2001). These observations indicated that HSV-2 co-infection might alter
the chlamydial developmental cycle in a way similar to that observed during persistent
infections.
Summary of Previous Co-infection Studies from Our Laboratory
Although previous studies on HSV-2/C. trachomatis co-infection suggested that
HSV-2 co-infection alters chlamydial development, these studies did not examine the coinfection process in detail. Recently, we developed a tissue culture model of HSV-2/C.
trachomatis serovar E co-infection. Data from this model indicate that HSV-2 superinfection of C. trachomatis-infected genital epithelial cells induces chlamydial
persistence, as evidenced by significantly decreased infectious chlamydial EB production,
abnormal RB morphology, increased membrane blebs and vesicles within inclusions, as
well as continued accumulation of chlamydial genomic DNA and unprocessed RNA, but
no infectivity (Deka et al., 2006).
Furthermore, co-infection of HeLa or HEC1B cells with C. trachomatis serovar E
and either HSV-2 or HSV-1 reduces chlamydial EB titer, alters inclusion ultrastructure
but does not reduce chlamydial DNA copy number, indicating that induction of
chlamydial persistence by HSV is neither host cell type nor virus strain specific (Deka et
al., 2007). UV-inactivated HSV (HSV-2uv) attaches to and enters host cells but does not
replicate (Moxley et al., 2002). Cyclohexamide, a well known eukaryotic protein
synthesis inhibitor, inhibits de novo synthesis of host cell proteins (Vasquez, 1979) and
all kinetic classes of HSV proteins as well as preventing HSV productive replication
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(Fenwick & Walker, 1978; Swanstrom et al., 1975) but does not affect C. trachomatis
development (Ripa & Mardh, 1977). Co-infection of HeLa cells with HSV-2uv or with
replication-competent HSV-2 in the presence of cyclohexamide continues to drive C.
trachomatis into a persistent state, suggesting productive HSV replication is not required
for induction of chlamydial persistence, and HSV attachment or entry is sufficient for this
effect (Deka et al., 2007).
Global deprivation of amino acids, iron, or glucose can cause developing
chlamydiae to enter persistence (Harper et al., 2000; Hogan et al., 2004; Raulston, 1997).
However, supplementation of HSV-2/C. trachomatis co-infected cells with excess amino
acids, iron-saturated transferrin, glucose, or a combination of amino acids and glucose
does not rescue EB infectivity, suggesting that viral co-infection-induced chlamydial
persistence is not due to amino acid, iron, or glucose deprivation (Vanover et al., 2008).
Luminex assays indicate that IFN-γ, IFN-α and TNF-α, three well-studied inducers of
chlamydial persistence, are not released from co-infected cells. Semiquantitative RT-PCR
experiments demonstrate that IFN-β, IFN-γ, IDO, lymphotoxin-α, and inducible nitric
oxide synthase (iNOS) are not expressed during co-infection. These data indicate that
viral-induced persistence is not stimulated by any cytokine currently known to induce
host anti-chlamydial responses (Vanover et al., 2008). Also, inclusions within co-infected
cells continue to enlarge and incorporate C6-NBD-ceramide, indicating that HSV-2 coinfection does not inhibit vesicular transport to the developing inclusion (Vanover et al.,
2008). Therefore, taken together, these data demonstrate that HSV co-infection-induced
chlamydial persistence is not mediated by any currently identified persistence inducer or
anti-chlamydial pathway (Vanover et al., 2008).
Studies show that persistent chlamydiae re-enter the normal developmental cycle
and re-gain infectivity following removal of persistence inducers or replacement of
deficient/depleted nutrients (Harper et al., 2000; Matsumoto & Manire, 1970; Raulston,
1997). Our unpublished data indicate that chlamydiae can recover infectivity within 44hr
during long-term co-infection with UV-inactivated HSV-2, demonstrating that, like other
persistence inducers, HSV-induced chlamydial persistence is reversible (Vanover, 2009b).
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Moreover, contact between paraformaldehyde-fixed, HSV-2-infected cells and viable C.
trachomatis-infected cells induces chlamydial persistence, indicating that HSV entry is
not required for chlamydial persistence induction and suggesting that interaction between
HSV surface glycoproteins and a host cell receptor is sufficient for triggering chlamydial
persistence (Vanover, 2009b). More importantly, subsequent studies in our laboratory
determined that HSV glycoprotein D interaction with host cell surface renders sufficient
stimulus to induce chlamydial persistence, probably via a novel host anti-chlamydial
pathway (Vanover, 2009b).
Questions to be Answered in the Studies
Upon infection, chlamydiae modulate host cell functions in a variety of ways in
order to ensure their replication, dissemination, and long-term survival within infected
hosts. It has been reported that C. trachomatis infection disturbs cell-cell contacts
between polarized epithelial cells in culture (Wyrick et al., 1989). Notably, release of C.
trachomatis-infected epithelial cells has been observed in vivo as well (Doughri et al.,
1972; Soloff et al., 1985). In both studies by Doughri et al and Soloff et al, the authors
hypothesized that polymorphonuclear neutrophils (PMNs) responding to chlamydial
infection promote detachment of chlamydia-infected cells from the mucosal surface,
resulting in the release of intact, infected cells into the cervical lumen (Doughri et al.,
1972; Soloff et al., 1985). However, in the absence of PMNs, Prozialeck et al have
observed that chlamydial infection also loosens cell-cell contacts by promoting
breakdown of the N-cadherin/β-catenin complex (Prozialeck et al., 2002), suggesting that
the developing chlamydiae may contribute directly to the release of observed in vivo of
infected cells from the infected mucosa. Recently, it has been elucidated that the nectinbased adhesion system is required not only for the formation of AJs but also for the
subsequent formation of TJs as well as for the formation and maintenance of functional
cell-cell junctions, acting cooperatively with or independently of cadherins (Takai &
Nakanishi, 2003). To find out whether C. trachomatis infection alters nectin-1 in genital
epithelial cells, we have systematically examined the accumulation and expression level
of nectin-1 using Western blotting, immunofluorescence assay and RT-PCR analyses.
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Our data indicated that nectin-1 accumulation is significantly decreased at the posttranscriptional level in C. trachomatis-infected genital epithelial cells and suggested that
C. trachomatis may disrupt AJs, at least in part, by diminishing nectin-1 expression. This
work has been published in Microbiology (2008, 154:1290-1299) (Sun et al., 2008) and is
presented here as Chapter 2.
CPAF, a chlamydia-secreted protease, has been reported to degrade a number of
host cell proteins during chlamydial infection, including transcription factors RFX5 and
USF-1, keratin-8, pro-apoptotic BH-3 only proteins, and CD1d glycoprotein (Dong et al.,
2004c; Kawana et al., 2007; Pirbhai et al., 2006; Zhong et al., 1999; Zhong et al., 2000).
Given the broad range of cellular proteins that CPAF targets, we hypothesized that CPAF
may degrade nectin-1 in C. trachomatis-infected genital epithelial cells. To elucidate the
molecular mechanism by which chlamydiae down-regulate nectin-1, we determined
whether or not CPAF degrades nectin-1. This work has been published in Microbes and
Infection (2009, 11:12-19) (Sun, 2009) and is presented here as Chapter 3.
HSV gD is the main determinant of cell recognition for viral entry. Fusion of the
HSV envelope and host cell membrane is mediated by the binding of HSV gD to one of
its co-receptors (HVEM, nectin-1, nectin-2 and 3-O-S-HS). Unpublished data from our
laboratory indicate that HSV glycoprotein D (gD) interaction with the host cell surface is
sufficient to induce chlamydial persistence (Vanover, 2009b). Subsequently, we
determined that virus interaction with one of the known co-receptors is sufficient to alter
the chlamydial developmental cycle. This work has been summarized in a manuscript
“Nectin-1 is required for Herpes simplex virus (HSV) co-infection-induced Chlamydia
trachomatis persistence” and is presented here as Chapter 4.
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THE HOST ADHERENS JUNCTION MOLECULE NECTIN-1 IS DOWNREGULATED IN CHLAMYDIA TRACHOMATIS-INFECTED GENITAL EPITHELIAL
CELLS
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Summary
Nectin-1, a member of the immunoglobulin superfamily, is a Ca2+-independent
cell adhesion protein implicated in the organization of E-cadherin-based adherens
junctions (AJs) and claudin-based tight junctions (TJs) in epithelial cells. Nectin-1 also
regulates cell–cell adhesion and cell polarization in a Cdc42- and Rac-dependent manner.
Western blot analyses demonstrated that accumulation of host nectin-1 is decreased by 85
% at 48 hours post-infection (h.p.i.) in Chlamydia trachomatis serovar E-infected HeLa
cells. Time-course experiments demonstrated that this decrease was sustained to 60 h.p.i.
Nectin-1 downregulation in C. trachomatis-infected cells was prevented by both
chloramphenicol exposure and prior inactivation of the chlamydiae with UV light,
demonstrating that active C. trachomatis replication was required. Penicillin G-exposure
studies demonstrated that nectin-1 accumulation was also altered during persistent
infection. Finally, RT-PCR analyses indicated that chlamydial infection did not alter
accumulation of any nectin-1 transcripts, demonstrating that nectin-1 accumulation is
reduced at a post-transcriptional level. Intesrestingly, N-cadherin-dependent cell–cell
junctions can be disrupted by C. trachomatis infection, as reported by Prozialeck et al.
(2002) . Because interaction of nectin molecules on adjacent cells is essential for AJ
formation, these data suggest that C. trachomatis may disrupt AJs, at least in part, by
diminishing nectin-1 accumulation. Notably, release of chlamydiae-infected epithelial
cells has been observed both in vitro from polarized monolayers and in vivo from tissues,
suggesting that chlamydia-modulated downregulation of adhesion molecules and the
subsequent disruption of host cell adherence may be involved in chlamydial
dissemination or pathogenesis.
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Introduction
The obligate intracellular bacterium Chlamydia trachomatis is a significant Gramnegative human pathogen, with 4 million new cases per year in the USA. Long-term C.
trachomatis genital tract infections are often asymptomatic and associated with severe
ascending complications, including epididymitis, prostatitis, ectopic pregnancy,
salpingitis, and infertility (Darville, 2000a). The chlamydial developmental cycle begins
when the elementary body (EB) binds to and enters mucosal epithelial cells. Once
internalized, the EB remains within an inclusion and differentiates into a reticulate body
(RB). Using host cell nutrients, the RB grows, divides by binary fission and eventually
produces more EBs, which are released by host cell lysis (Wyrick, 2000). When
developing chlamydiae are confronted with nutrient deficiency or penicillin exposure,
they deviate from the normal developmental cycle and enter into a state called persistence,
which is characterized by formation of aberrantly enlarged, viable but non-infectious
chlamydial RB (Hogan et al., 2004). Notably, the chlamydiae can re-enter and complete
the normal developmental cycle once the persistence “inducer” is removed.
Upon infection, chlamydiae alter host cellular functions in a variety of ways.
Chlamydial infection prevents host cell apoptosis, induces reorganization of the actin
cytoskeleton, and alters host cellular signaling mechanisms (Hackstadt, 1999; Hatch,
1999). C. trachomatis infection also disturbs cell-cell contacts between polarized
epithelial cells in culture (Wyrick et al., 1989). This cell-cell disassociation was later
shown to be due, at least in part, to disruption of N-cadherin-dependent cell-cell junctions
and breakdown of the N-cadherin/β-catenin complex (Prozialeck et al., 2002). Notably,
infected epithelial cell release has also been observed in vivo (Doughri et al., 1972; Soloff
et al., 1985). Doughri et al further suggest that release of chlamydiae within intact host
cells might protect the organisms from anti-chlamydial antibodies (Doughri et al., 1972).
In both studies, the authors hypothesize that PMNs responding to chlamydial infection
promote detachment of chlamydia-infected cells from the mucosal surface, resulting in
the release of intact, infected cells into the cervical lumen (Doughri et al., 1972; Soloff et
al., 1985). The seminal observation that chlamydial infection in the absence of PMNs
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loosens cell-cell junctions by promoting breakdown of the N-cadherin/β-catenin complex
(Prozialeck et al., 2002) suggests that the developing chlamydiae may also directly
contribute to the release of infected cells from the infected mucosa observed in vivo.
In epithelial cells, junctional complexes, which are composed of tight junctions
(TJs), adherens junctions (AJs), and desmosomes (DSs), play critical roles in forming
intercellular adhesions. Intercellular adhesions, in turn, are intimately involved in
maintaining cell structure, transmitting information, regulating cellular migration, and
imparting strength and rigidity to tissues (Farquhar & Palade, 1963; Gumbiner, 1996;
Lauffenburger & Horwitz, 1996; Takeichi, 1995). Importantly, the organization and
function of TJs and DSs are dependent on the formation and maintenance of AJs (Tsukita
& Furuse, 1999). AJs are located at the basal side of TJs and connect the lateral surfaces
of adjacent epithelia cells. AJs form complexes with actin and myosin filaments to
internally brace cells and thereby control their shape. E-cadherin and claudin are two
well-studied cell-cell adhesion molecules found in AJs and TJs, respectively.
A novel cell-cell adhesion system consisting of nectin and afadin has recently
been identified at AJs in epithelial cells, neurons, and fibroblasts (Takai & Nakanishi,
2003). Nectins are Ca2+-independent, Ig-like cell-cell adhesion molecules with three
extracellular Ig-like loops, a single transmembrane region (except for nectin-1γ) and a
cytoplasmic tail. The nectin family currently contains 4 members (nectins-1~4) (Sakisaka
& Takai, 2004; Takai & Nakanishi, 2003). Afadin is a nectin- and F-actin-binding protein
that connects the trans-membrane domain of nectin to the actin cytoskeleton (Takai &
Nakanishi, 2003). This nectin-based adhesion system is required not only for the
formation of AJs but also for the subsequent formation of TJs (Takai & Nakanishi, 2003).
Furthermore, activation of Cdc42 and Rac small G proteins through c-Src by transinteraction of nectins has been implicated in controlling cell-cell adhesion and cell
polarization (Takai et al., 2003).
In this study, Western blot analyses demonstrate that accumulation of host nectin1 is significantly decreased in C. trachomatis serovar E-infected cervical epithelial cells.
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This down-regulation requires active C. trachomatis protein synthesis and/or replication.
RT-PCR analyses further show that reduced expression of nectin-1 likely occurs posttranscriptionally. Because the nectin-afadin adhesion system is critical for formation of
functional E-cadherin based AJs and subsequent claudin-based TJs, and because
chlamydial infection has been previously shown to disrupt cell:cell junctions (Prozialeck
et al., 2002), our data suggest that C. trachomatis may disrupt AJs, at least in part, by
diminishing nectin-1 expression.
Methods
Cell culture, chlamydial infection and titrations.
HeLa cells, a human cervical adenocarcinoma epithelial cell line (ATCC No.
CCL2), were cultured as described (Deka et al, 2006). A human urogenital isolate of C.
trachomatis E/UW-5/CX was originally obtained from S.P. Wang and C.C. Kuo
(University of Washington, Seattle, WA). The same standardized inoculum of C.
trachomatis serovar E EBs, propagated in McCoy cells, was used for all experiments
(Wyrick et al., 1996). For infection experiments, HeLa cells were either grown in
standard tissue culture plates or were polarized on 3.0 µm, Collagen IV-coated chamber
inserts (Biocoat 4544, Becton Dickinson) as described (Wyrick et al., 1989). Host cells
were infected at a multiplicity of infection (MOI) of 1 using crude EB stock, which
infects ~ 90% of the HeLa cells, for 1 hour at 35°C. In some experiments, HeLa cells
were infected with an equivalent amount of UV-inactivated C. trachomatis serovar E (C.
trachomatis-UV). Mock-infected host cells were treated similarly except they were
exposed to 200 µl of 2SPG (0.2 M sucrose, 6 mM NaH2PO4, 15 mM Na2HPO4, 5 mM Lglutamine, pH 7.2). After infection, the inoculum was aspirated and the infected cells
were refed with growth medium and incubated at 35°C for the indicated times.
Chlamydial titrations were performed as previously described (Deka et al., 2007). Each
experiment was repeated three times and each repeat contained three biological replicates.
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Generation of C. trachomatis-UV.
A UV cross-linker (Spectrolinker XL1500, Spectronics Corporation) was used to
generate stocks of UV-inactivated, replication-incompetent C. trachomatis (C.
trachomatis-UV). Stock C. trachomatis serovar E was thawed on ice and 200 µl was
aliquoted into each well of a 24-well plate. The plate was placed on a 4ºC heat sink
during UV exposure to prevent heat inactivation of the samples. EB inactivation was
assayed by performing chlamydial titrations (Deka et al., 2007). A UV dose of 1.0 J cm-2
was sufficient to completely inactivate undiluted C. trachomatis stocks (data not shown).
RNA and DNA isolation.
Total RNA and DNA were isolated from mock- or C. trachomatis-infected HeLa
cells at 48 hpi and 60 hpi using the method previously described by Deka et al (Deka et
al., 2006). Total RNA and DNA preparations were quantified by measuring optical
density (OD) at 260 and 280 nm. All samples had OD260/280 ratios > 1.9. The quality and
concentration of each RNA sample were further confirmed by analysis on a 2100
Bioanalyzer instrument (Agilent) using the RNA 6000 Nano LabChip kit. All samples
had RNA Integrity Numbers (RINs) between 9.0-10.0 (data not shown).
PCR, Reverse transcription and RT-PCR.
Total cellular DNA was used as a template to amplify human glyceraldehyde-3phosphate dehydrogenase (GAPDH) for determination of host genome copy number.
Total cellular RNA samples were subjected to reverse transcription as previously
described (Deka et al., 2006), except that two micrograms of total RNA was used. RTPCR reactions were than carried out using RT(+) and RT(–) cDNA reactions as templates,
as appropriate. Experimental template DNAs/cDNAs were used in PCR reactions at
dilutions ranging from 1/10 to 1/1000 (in ddH2O), such that each reaction was in the
linear amplification range. The amplification conditions were based on those previously
described (Deka et al., 2006). Published primer sets included human β-actin (Nelson et
al., 2005) and human GAPDH (Deka et al., 2006). Specific primers and positive
oligonucleotide amplification controls for human nectin-1α, nectin-1β and nectin-1γ were
designed using Oligo 4.0 software. They are listed in supplementary Table S1. Most
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reactions were cycled as follows: 94°C, 1 min; 60°C, 1 min; 72°C, 1 min for 35 cycles.
Human β-actin reactions were performed under identical conditions but were cycled 30
times; human GAPDH PCR reactions were performed for 35 cycles and annealed at 67°C.
The resulting PCR products were separated by electrophoresis on 2.5% agarose/TBE gels
and stained with ethidium bromide. A Bio-Rad Chemi Doc XRS Image Capture System
with Quantity One V4.5.0 software was used to visualize and quantify amplimers.
SDS-PAGE and Western blotting.
Monolayers were lysed and denatured as described (Deka et al., 2006). Samples
were then normalized for total protein content using SYPRO Ruby stain (BioRad)
according to the manufacturer’s instructions. Samples were diluted to identical
concentrations, subjected to SDS-polyacrylamide gel electrophoresis (PAGE), and
Western blotted (Deka et al., 2006). Primary antibodies used included mouse monoclonal
anti-nectin-1 CK6 (1:200 dilution, sc-21722, Santa Cruz Biotechnology), mouse
monoclonal anti-nectin-1 CK8 (1:200 dilution, 37-5900, Invitrogen-Zymed), rabbit
polyclonal anti-human focal adhesion kinase (FAK) C-20 (1: 2000 dilution, sc-558, Santa
Cruz Biotechnology), and goat polyclonal anti-MOMP (1:5000 dilution, B65266G,
BioDesign International). Bound primary antibodies were detected using corresponding
secondary antibodies conjugated to horseradish peroxidase and visualized using
SuperSignalWest Pico reagent (Pierce). Specific bands were quantified using an FX
phosphorimager and Quantity One V2.5.0 software (Bio-Rad). To control for small
variations in cell number and gel loading between sample lanes, nectin-1 quantity in each
sample was normalized to the amount of FAK protein detected in that same lane.
Previous studies from our laboratory have demonstrated that FAK accumulation is not
altered by chlamydial infection and , therefore, makes an ideal internal control (Deka et
al., 2006).
Statistical analyses.
Statistical analyses were performed using Microsoft Excel. A two-sample t-test
for independent samples was used for comparison of means. Significance was defined as
P ≤ 0.05.
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Results
Nectin-1 accumulation is reduced in C. trachomatis-infected HeLa cells.
Nectin-1 is an important cell-cell adhesion molecule involved in the formation
and maintenance of AJs and TJs. Previous studies demonstrated that cell:cell contacts are
disrupted in C. trachomatis-infected cervical epithelial cells (Prozialeck et al., 2002). To
determine whether chlamydial infection modulates nectin-1 expression, monolayers of
non-polarized HeLa cells were either mock- or C. trachomatis serovar E-infected at a
MOI of 1. Cell lysates were collected 48 hpi and processed for SDS-PAGE analyses.
Duplicate gels were either stained with SYPRO Ruby (data not shown) or Western
blotted (Fig. 2.1a) using anti-nectin-1 CK6 mAb, anti-C. trachomatis MOMP or antiFAK as described (Deka et al., 2006). Nectin-1 bands were quantified, normalized to
FAK and plotted in Fig. 2.1(b). Focal adhesion kinase (FAK) was chosen as an internal
control protein because FAK accumulation is not altered by chlamydial infection (Deka
et al., 2006). As expected, MOMP expression was detected only in C. trachomatisinfected cells. Nectin-1 accumulation was decreased by up to 85% in C. trachomatisinfected HeLa cells compared to that in mock-infected controls. Sequential
immunoprecipitation and blotting experiments with a different nectin-1-specific
monoclonal antibody (Supplementary Fig. S2.1b) confirmed that the protein detected on
the blots in Fig. 2.1 was indeed nectin-1. Additionally, little or no nectin-1 was
immunoprecipitated from chlamydia-infected cells harvested at 48 hpi by either antibody,
confirming the observations described above.
In vivo, polarized epithelial cells differentially distribute proteins and lipids to the
plasma membrane, creating two distinct surfaces -- the apical and basolateral domains.
Previous studies have shown that polarized and non-polarized cells differ in C.
trachomatis infection efficiency, duration of the C. trachomatis developmental cycle and
their response to IFN-γ (Arno et al., 1990; Kane & Byrne, 1998; Tam et al., 1992). Thus,
we wanted to investigate whether or not the polarity of epithelial cells would affect the
observed nectin-1 reduction. Western blotting analyses (Supplementary Fig.S2.2a)
showed that nectin-1 was also down-regulated in C. trachomatis-infected polarized cells.
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At 48 hpi, nectin-1 accumulation was decreased as much as 88% in C. trachomatisinfected polarized HeLa cells compared to that in mock-infected controls (Supplementary
Fig. S2.2b). Because similar results were obtained from both non-polarized and polarized
HeLa cells, non-polarized cells were used in subsequent experiments.
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Figure 2.1 Nectin-1 accumulation is reduced in C. trachomatis-infected HeLa cells. HeLa
cells were either mock- or C. trachomatis serovar E-infected at a MOI of 1. Cell lysates
were collected 48 hpi and Western blotted using anti-nectin-1 CK6, anti-C. trachomatis
MOMP or anti-FAK (C-20). Nectin-1 bands were quantified, normalized to the internal
control protein FAK and plotted in (b). Results are expressed as the average of three
biological replicates ± SEM. P ≤ 0.05 was considered significant. Groups significantly
different from the mock-infected controls are indicated by asterisks (*). These data are
representative of three independent experiments.

Nectin-1 accumulation is reduced in C. trachomatis-infected HeLa cells from 36 to 60
hpi.
To more precisely define when down-regulation of nectin-1 occurs during the C.
trachomatis developmental cycle, an infection time course ranging from 0 to 60 hpi was
conducted. HeLa cells were either mock- or C. trachomatis-infected. Cell lysates were
collected at 0, 24, 36, 48 and 60 hpi and Western blotted with (i) anti-nectin-1 (CK6), (ii)
anti-FAK (C-20) and (iii) anti-MOMP. A representative blot is shown in Fig. 2.2(a); the
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quantification of this blot is shown in Fig. 2.2(b). The nectin-1 quantity observed in C.
trachomatis-infected cells from three independent experiments was expressed as a
percentage of that observed in mock-infected control cells at each time interval and
plotted (Fig. 2.2c). These data demonstrate that C. trachomatis infection significantly
reduced accumulation of nectin-1 starting at 36 hpi and the reduction was maximal at 60
hpi.
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Figure 2.2 Nectin-1 accumulation is reduced in C. trachomatis-infected HeLa cells from
36 to 60 hpi. (a) Cell lysates from mock- or C. trachomatis-infected HeLa cells were
collected at 0, 24, 36, 48, 60 hpi and Western blotted using anti-nectin-1 CK6, anti-C.
trachomatis MOMP or anti-FAK (C-20). (b) The quantity of nectin-1 detected in panel (a)
was normalized to the internal control protein FAK and plotted. (c) Nectin-1 quantity
observed in C. trachomatis-infected cells was expressed as a percentage of that observed
in mock-infected control cells at each time interval. Results are expressed as the average
of three biological replicates ± SEM. P ≤ 0.05 was considered significant. Groups
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significantly different compared to C. trachomatis-infected cells at 0 hpi are indicated by
asterisks (*). These data are representative of three independent experiments.

Nectin-1 down-regulation requires C. trachomatis protein synthesis and/or replication.
To extend these findings, we next investigated whether C. trachomatis protein
synthesis and/or replication was required for nectin-1 down-regulation. Nectin-1
expression in persistently-infected cells was also examined. HeLa cells were either mockor C. trachomatis-infected and refed immediately after infection with growth medium
plus ddH2O, medium plus 60 µg chloramphenicol ml-1 (Camp, which specifically inhibits
function of bacterial 50S ribosomal subunits) or medium plus 20 units penicillin G ml-1
(PenG, a known inducer of chlamydial persistence). Cell lysates were harvested at 48 hpi
for Western blot analyses (Fig. 2.3a, b). Nectin-1 quantity observed in C. trachomatisinfected cells from three independent experiments was expressed as a percentage of that
observed in mock-infected control cells under that set of experimental conditions (Fig.
2.3c). As a control to confirm that each antibiotic was working as expected, duplicate
cultures from each drug-exposure group were subjected to chlamydial sub-passage
titration analyses. The number of inclusion-forming units (IFU) in the undiluted inocula
was then calculated and expressed as IFU ml-1 (Fig. 2.3d). Nectin-1 down-regulation in C.
trachomatis-infected cells was prevented by chloramphenicol exposure (Fig. 2.3a, lanes 5
and 6), demonstrating that C. trachomatis protein synthesis and/or replication is required
for this effect. Nectin-1 levels also decreased in the presence of penicillin G (Fig. 2.3a,
lanes 7 and 8), although to a lesser degree than that observed in diluent-exposed,
chlamydiae-infected monolayers (Fig. 2.3b, c). These data indicate that nectin-1
accumulation can also be reduced by penicillin-induced, persistent C. trachomatis
infection. Chlamydial sub-passage experiments demonstrate that both chloramphenicol
and penicillin G exposure significantly reduced recovery of infectious EB, as expected
(Fig. 2.3d).
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Figure 2.3 C. trachomatis protein synthesis and/or replication is/are required for nectin-1
down-regulation. (a) Cells were refed immediately after C. trachomatis-infection with
growth medium + ddH2O, 60 µg chloramphenicol ml-1 (Camp) or 20 units penicillin G
ml-1 (PenG). Cell lysates were harvested at 48 hpi and Western blotted using anti-nectin1 CK6, anti-C. trachomatis MOMP or anti-FAK (C-20). (b) The quantity of nectin-1
detected on the blot in panel (a) was normalized to FAK and plotted. (c) Nectin-1
quantity observed in C. trachomatis-infected cells was expressed as a percentage of that
observed in mock-infected control cells under that set of experimental conditions. The
average from three biologic replicates ± SEM is shown. P ≤ 0.05 was considered
significant. Groups significantly different compared to Camp-exposed, C. trachomatisinfected cells are indicated by asterisks (*). (d) Duplicate cell cultures from each drugexposure group were subjected to chlamydial sub-passage titration. Results are expressed
as the average of three biological replicates ± SEM. Significance was defined as P ≤ 0.05.
Groups significantly different compared to non-drug exposed, C. trachomatis-infected
cells are indicated by asterisks (*). All data shown here are representative of three
independent experiments.
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Viable C. trachomatis EBs are required for nectin-1 down-regulation.
To determine if viable C. trachomatis EBs are required for down-regulation of
nectin-1, UV-inactivated C. trachomatis was used to infect HeLa cells. Previous studies
have demonstrated that UV-inactivation of C. trachomatis renders the bacteria
completely replication-incompetent (Eissenberg et al., 1983). HeLa cultures were mock-,
C. trachomatis-, or C. trachomatis-UV-infected, collected at 48 hpi and processed for
Western blot analyses (Fig. 2.4a). Average nectin-1 accumulation was quantified,
normalized and plotted (Fig. 2.4b). Nectin-1 accumulation was reduced in C.
trachomatis-infected cells but not in cultures infected with an equivalent quantity of UVinactivated C. trachomatis EB, demonstrating that nectin-1 is down-regulated only if
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Figure 2.4 Viable C. trachomatis EBs are required for nectin-1 down-regulation. (a)
HeLa cells were mock-, C. trachomatis-, or C. trachomatis-UV-infected. Cells were
collected at 48 hpi and Western blotted using anti-nectin-1 CK6, anti-C. trachomatis
MOMP or anti-FAK (C-20). (b) The quantity of nectin-1 was normalized to internal
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replicates ± SEM. Significance was defined as P ≤ 0.05. Groups significantly different
from the mock-infected controls are indicated by asterisks (*).The data shown here are
representative of three independent experiments.
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C. trachomatis infection of HeLa cells does not alter accumulation of nectin-1α, β and γ
transcripts.
Nectin-1 has three splice variants: nectin-1α, nectin-1β, and nectin-1γ. All three
nectin-1 isoforms encoded by these transcripts associate with other adhesion molecules
and play important roles in the formation of cell-cell junctions. Although the nectin-1α
and nectin-1β proteins both contain the CK6 and CK8-reactive epitopes (Supplementary
Fig. S2.1a), the observed molecular weight (75kD) is most consistent with the reported
size for nectin-1α (Struyf et al., 2005) . To aid in elucidating the mechanism by which
host cell nectin-1 expression is altered in response to C. trachomatis infection, we
investigated whether down-regulation of nectin-1 occurs at the transcriptional level. Total
RNA from mock- or C. trachomatis-infected cells was isolated and subjected to RT-PCR
using primers specific for human β-actin, nectin-1α, nectin-1β, and nectin-1γ transcripts.
Parallel total DNA samples were amplified using GAPDH-specific primers to determine
host genome copy number. All amplimers were the expected size (Fig. 2.5a) and the
identity of each was confirmed by DNA sequencing (data not shown). In each experiment,
a six log dilution series of known DNA template controls was used to generate
amplification standard curves. Experimental samples were only quantified if they fell
within the linear range of the PCR. Amplification products were not observed in
template-negative samples (Fig. 2.5a, lane 1) or in RT(-) controls (data not shown). The
quantity of nectin-1α, β and γ products was similar in mock- compared to C. trachomatisinfected samples at both 48 and 60 hpi (Fig. 2.5a, lanes 2-5). All amplimers were
quantified, normalized to host genome copy number as ascertained by PCR with human
GAPDH-specific primers, and plotted in Fig. 2.5(b). Statistical analyses showed that
there was no significant difference in accumulation of any of the nectin-1 transcripts in
mock- versus C. trachomatis-infected cells (Fig. 2.5b). These data indicate that
expression of nectin-1 was not regulated at the transcriptional level and, thus, was likely
regulated post-transcriptionally.
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Discussion
Chlamydiae have evolved various strategies to avoid host defense systems and
complete their intracellular growth cycle. Chlamydiae have acquired specific mechanisms
to prevent productively and persistently infected cells from undergoing apoptosis (Dean
& Powers, 2001; Fan et al., 1998; Fischer et al., 2004; Geng et al., 2000; Pirbhai et al.,
2006; Rajalingam et al., 2001), which may allow chlamydiae to maintain long-term
survival within infected cells. Chlamydiae also alter host cell:cell contacts and signal
transduction (Prozialeck et al., 2002; Xia et al., 2003), which may facilitate chlamydial
growth. Finally, chlamydiae also modify the host cell cytoskeleton (Dong et al., 2004c;
Majeed et al., 1993), which may benefit chlamydial intravacuolar replication. In the
present study, we observed a remarkable loss of nectin-1 in C. trachomatis-infected HeLa
cells. We further demonstrated that active C. trachomatis protein synthesis and/or
replication and viable C. trachomatis EBs are required for this effect. Lastly, we also
noted that persistent chlamydial infection, induced by penicillin G, also down-regulates
nectin-1 accumulation. Because different persistence inducers act upon the developing
chlamydiae by divergent mechanisms, we must examine other stressors to determine
whether the nectin-1 decrease is a general characteristic of persistently-infected epithelial
cells.
It is currently accepted that nectin-1 plays a critical role in the formation and
maintenance of adherens junctions (AJs) and tight junctions (TJs). Disruption of nectin-1
would inevitably affect the integrity of cell-cell junctions, which may be implicated in
chlamydial pathophysiologic effects on the host. This notion is consistent with a recent
study showing that cervical epithelial cells separate from each other as a consequence of
C. trachomatis infection (Prozialeck et al., 2002). Interestingly, the important human
pathogens Helicobacter pylori, Shigella flexneri, and Salmonella typhimurium also downregulate essential components of adhesion and tight junctions, including E-cadherin,
claudin-1, and ZO-1. This leads to decreased transepithelial electrical resistance and
increased paracellular permeability, which facilitates cell-to-cell spreading of these
pathogens (Jepson et al., 1995; Sakaguchi et al., 2002; Sears, 2000; Terres et al., 1998).
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Collectively, these findings suggest that disruption of adhesion and tight junctions to
compromise cell-cell barriers may be an important strategy exploited by intracellular
pathogens to manipulate host cells. Although C. trachomatis serovar E is not an invasive
pathogen, it may diminish nectin-1 expression to aid lateral cell to cell spread.
Surprisingly, in contrast to C. trachomatis and the pathogens mentioned above, C.
pneumoniae up-regulates the expression of adherens junction proteins VE-cadherin, Ncadherin, and β-catenin and transiently down-regulates the expression of the tight
junction protein occludin to alter junctional complexes, facilitating its transmission in
human brain microvascular endothelial cells (MacIntyre et al., 2002). It is currently
unknown why C. trachomatis and C. pneumoniae might use two distinct mechanisms to
interact with junctional complexes.
While nectin-1 protein expression was decreased in C. trachomatis-infected
HeLa cells, accumulation of nectin-1α, β and γ transcripts was unchanged. These data
indicate that reduction of nectin-1 was not regulated transcriptionally and, thus, is likely
down-regulated at the post-transcriptional level. Recently, several host proteins have been
reported to undergo degradation upon C. trachomatis infection (Balsara et al., 2006;
Dong et al., 2004c; Dong et al., 2005a; Fischer et al., 2004; Pirbhai et al., 2006; Ying et
al., 2005; Zhong et al., 1999; Zhong et al., 2000). The chlamydia-secreted protease
CPAF (chlamydial protease/proteasome-like activity factor) is responsible for the
degradation of many of these host proteins. Given the broad range of cellular proteins
cleaved by CPAF, it is possible that CPAF could also degrade nectin-1. Notably, there is
little or no difference in CPAF expression between productive and persistent infections
(Heuer et al., 2003; Shaw et al., 2002). Thus, the observation that nectin-1 was decreased
in both C. trachomatis productively- and persistently-infected samples is consistent with
the notion that CPAF degrades nectin-1. Alternatively, it is also possible that chlamydial
infection induces a host cell derived protease or proteosomal activity which degrades
nectin-1. The role of CPAF and other chlamydial or host derived proteases in regulating
nectin-1 accumulation in chlamydiae-infected cells requires further investigation.
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Although the mechanism by which C. trachomatis down-regulates nectin-1
expression is of significant interest, a more important question remains--why does C.
trachomatis reduce host cell nectin-1 accumulation? There are at least two plausible
hypotheses. First, nectin-1 down-regulation, and subsequent disruption of cell:cell
adhesions, may facilitate host structural rearrangements required for inclusion
enlargement or EB release at the end of the developmental cycle. This prediction is
supported by the observation that nectin-1 accumulation starts decreasing at 36 hpi,
which is mid-developmental cycle for C. trachomatis serovar E. The second, and perhaps
more intriguing possibility, is that nectin-1 down-regulation facilitates C. trachomatis
dissemination within the host genital tract (Supplementary Fig. S3). In this case,
weakening of contacts between an infected genital epithelial cell and adjacent, uninfected
cells would allow release of the intact, infected cell into the genital tract lumen. The
infected cell would then drift away from original infection site in the genital mucus,
aiding chlamydial dissemination in at least two ways. First, chlamydial EB within the
exfoliated cell would be shielded from neutralization by secretory IgA, cationic antimicrobial peptides (CAMPs) and other anti-bacterial compounds, as long as the host cell
remained intact. Second, if the infected cell ruptured in close proximately to the genital
mucosa, the local concentration of infectious EB would be very high, increasing the
probability that mucosal epithelia in the vicinity would be successfully infected. In
contrast, EB released from host cells still within the genital epithelial layer
(Supplementary Fig. S3, right) would be both quickly diluted and immediately subject to
neutralization by anti-bacterial compounds. Therefore, only host cells in close proximity
to the release site would have a high probability of becoming infected. Thus, we envision
that the released, inclusion-containing epithelial cell would act like a chlamydial “cluster
bomb”, allowing delivery of a concentrated inocula over a relatively long distance and
increasing the possibility of a “hit” if the host cell ruptured near the genital epithelial cell
layer. Interestingly, release of intact, chlamydiae-infected host cells has been observed
from polarized monolayers in culture (Wyrick et al., 1989) as well as from infected
epithelium in vivo (Doughri et al., 1972; Soloff et al., 1985). Of course, it is always
possible that the observed nectin-1 decrease is an indirect side-effect of other host
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cytoskeletal or physiologic alterations induced during chlamydial infection. Future
studies will be directed toward determining which of these hypotheses are correct.
Finally, it should be noted that nectin also plays a critical role in intracellular
signaling. Recent studies have demonstrated that Cdc42 and Rac small G proteins are
activated by trans-interactions of nectin in a PI3 kinase-independent manner in epithelial
cells (Honda et al., 2003; Kawakatsu et al., 2002). Although the precise mechanisms of
this activation remain to be elucidated, Cdc42 and Rac activities are required for the
formation and maintenance of AJs in epithelial cells (Braga et al., 1997; Braga et al.,
1999; Etienne-Manneville & Hall, 2002; Takaishi et al., 1997; Van Aelst & Symons,
2002). It is reasonable to speculate that the disruption of cell-cell junctions observed by
Prozialeck et al (Prozialeck et al., 2002) upon C. trachomatis infection may result from
insufficiently activated Cdc42 and Rac in response to reduced levels of nectin-1.
Furthermore, activated Cdc42 and Rac stimulate the c-Jun N-terminal kinase (JNK)
signaling pathway (Honda et al., 2003), which has been implicated in regulating cell
growth, transformation and apoptosis (Johnson & Lapadat, 2002; Lin, 2003). As
previously discussed, chlamydial infection strongly inhibits host cell apoptosis and it is
possible that reduced nectin-1/JNK signaling may play a role in this inhibition. Given the
known interplay between nectin-1 and host cellular signaling pathways, dissecting the
effect of C. trachomatis infection on nectin-mediated signal transduction events will be a
key aspect of future experiments.
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Supplementary Figure 2.1 Nectin-1 antibodies CK6 and CK8 detect the same protein.
Mock- (lanes 1, 3 and 5) or C. trachomatis-infected (lanes 2, 4 and 6) HeLa monolayers
were harvested at 48 hpi in 1X IP lysis buffer (Saltarelli et al., 1993). Cell lysates were
homogenized by passing them through a 20-gauge needle 10 times and were quantified
using a Bradford protein assay. Equivalent amounts of protein from each lysate were
immunoprecipitated using either nectin-1-specific mAb CK6 (lanes 1 and 2), nectin-1specific CK8 mAb (#37-5900, Invitrogen-Zymed; lanes 3 and 4) or protein A beads alone
(#17-0974-01, Amersham Pharmacia Biotechnology; lanes 5 and 6). These antibodies
recognize two overlapping linear epitopes between nectin-1 amino acids 80 and 104 [Fig.
S2.1a, boxed sequence (Krummenacher et al., 2000)]. Immunoprecipitates were then
boiled for 10 min, electrophoresed and then Western blotted using either CK6 (Fig. S2.1b,
left panel) or CK8 (Fig. S2.1b, right panel) to detect nectin-1. Both CK6 and CK8 mAbs
immunoprecipitated identically sized 75kD proteins from mock-infected cells but not
from C. trachomatis-infected cells (Fig. S2.1b), confirming that this protein was indeed
nectin-1. Additionally, little or no nectin-1 is immunoprecipitated from chlamydiainfected cells, which is consistent with previous observations. The 50 and 25 kD bands
are heavy and light chains from the immunoprecipitating antisera that are detected by the
anti-mouse secondary antibody. The data shown here are representative of three
independent experiments.
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Supplementary Figure 2.2 Nectin-1 accumulation is reduced in C. trachomatis-infected
polarized HeLa cells. Polarized HeLa cells were either mock- or C. trachomatis serovar
E-infected at an MOI of 1. Cell lysates were collected 48 hpi and Western blotted using
anti-nectin-1 CK6, anti-C. trachomatis MOMP or anti-FAK (C-20). Nectin-1 bands were
quantified, normalized to the internal control protein FAK and plotted in (b). Results are
expressed as the average of three biological replicates ± SEM. P ≤ 0.05 was considered
significant. Groups significantly different from the mock-infected controls are indicated
by asterisks (*). These data are representative of three independent experiments.
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Supplementary Figure 2.3 Potential role of nectin-1 down-regulation in C. trachomatis
dissemination within the host genital tract. See the text for a detailed description of the
figure. Red dots represent EBs; green circles represent RBs.
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Supplementary Table S2.1. RT-PCR primers and positive control oligonucleotides.
Name
hNectin-1α
hNectin-1β
hNectin-1γ

Forward primer
AGCACCAAGAAGCACGTGTA
CCCAGCAGGCAAAGC TC
GCATGGGCTTGATGTCAG

Reverse primer
GGCCTTCTTCTCGTCGTCT
CAGGGACAGCTTCTGCAAGT
TCATACTGTCCCCGTTTTACA

hNectin-1α
positive
control oligo

AGCACCAAGAAGCACGTGTATGGCAACGGCTACAGCAAGGCA
GGCATCCCCCAGCACCACCCACCAATGGCACAGAACCTGCAG
TACCCCGACGACTCAGACGACGAGAAGAAGGCC

hNectin-1β
positive
control oligo

CCCAGCAGGCAAAGCTCCCTTGTGCCTGAGGATATCCAGGTTG
TCCACCTGGACCCAGGGAGGCAGCAGCAGCAAGAAGAGGAGG
ACTTGCAGAAGCTGTCCCTG

hNectin-1γ
positive
control oligo

GCATGGGCTTGATGTCAGACAGCTGTGACCCTGGACAGGGCCC
CCCCCACCATCTGTAAAACGGGGACAGTATGA
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Abstract
Nectin-1 is an adhesion protein implicated in the organization of adherens junctions and
tight junctions in epithelial cells. Previous studies in our laboratory demonstrated that
nectin-1 accumulation was significantly decreased in Chlamydia trachomatis-infected
HeLa cells. In the present study, Western blot analyses indicated that nectin-1 downregulation was C. trachomatis concentration-dependent. The half life of nectin-1 was also
greatly diminished in C. trachomatis-infected cells compared to that observed in mockinfected cells, indicating that nectin-1 was likely down-regulated post-translationally. The
chlamydia-secreted protease CPAF is known to degrade several important host proteins;
CPAF expression within infected cells correlated with the time-dependent cleavage of
nectin-1. Notably, CPAF proteolytic activity is inhibited by lactacystin but not by the
proteosome inhibitor MG132. In vivo inhibition experiments demonstrated that nectin-1
down-regulation was blocked by lactacystin exposure. In contrast, MG132 had no effect.
Finally, cell-free cleavage assays demonstrated that functional recombinant GST-CPAFwt
protein degrades nectin-1. This degradation was blocked by lactacystin, as previously
observed in vivo. Collectively, these results indicate that nectin-1 is degraded by CPAF
in C. trachomatis-infected cells, a novel strategy that chlamydiae may use to aid their
dissemination.
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Introduction
Chlamydia trachomatis is a Gram-negative, obligate intracellular bacterium that is
one of the leading causes of sexually transmitted disease and the most common cause of
preventable blindness worldwide. Long-term C. trachomatis genital tract infections are
often chronic and asymptomatic, leading to severe complications including epididymitis
and prostatitis in men as well as pelvic inflammatory disease, ectopic pregnancy and
infertility in women (Darville, 2000a). C. trachomatis alternates between two
morphologically distinct forms and has a unique biphasic developmental cycle. This
cycle begins when infectious but metabolically inactive elementary bodies (EB) bind to
and enter mucosal epithelial cells. Once internalized, the EBs remain within a membranebound inclusion and transform into non-infectious but metabolically active reticulate
bodies (RB). Using nutrients from host cell, the RBs multiply, divide by binary fission
and eventually differentiate back into EBs, which are then released from the host cell
(Wyrick, 2000).
To ensure their successful intracellular replication and long-term survival within
infected hosts, chlamydiae have developed various strategies to evade host defense
systems. Recently, a chlamydia-secreted protein, designated chlamydia protease-like
activity factor (CPAF), has been identified. CPAF is hypothesized to play important roles
in promoting chlamydial replication and protecting infected cells from host immune
detection (Dong et al., 2004c; Kawana et al., 2007; Pirbhai et al., 2006; Zhong et al.,
1999; Zhong et al., 2000; Zhong et al., 2001). CPAF is synthesized in chlamydial
inclusions and subsequently secreted into the cytoplasm of infected host cells (Fan et al.,
2002; Zhong et al., 2001). CPAF is initially produced as an inactive proenzyme of ~70
kDa and rapidly processed into two fragments, a 35 kDa C-terminal portion (CPAFc) and
a 29 kDa N-terminal portion (CPAFn), which must form intramolecular dimers to acquire
proteolytic activity (Dong et al., 2004a; Dong et al., 2004b; Zhong et al., 2001).
Furthermore, the proteolytic activity of CPAF is inhibited by the cytosolic proteasome
inhibitor lactacystin but not by other proteasome inhibitors such as MG132 and MG115
or by broad spectrum protease inhibitors such as PMSF and pepstatin A (Zhong et al.,
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2000; Zhong et al., 2001). Moreover, CPAF is responsible for degrading host
transcription factors USF-1 and RFX5, required for host cell major histocompatibility
complex (MHC) class І and ІІ antigen activation (Zhong et al., 1999; Zhong et al., 2000).
Similarly, CPAF was found to be both necessary and sufficient for cleaving keratin 8
(Dong et al., 2004c), pro-apoptotic BH3-only proteins (Pirbhai et al., 2006), and CD1d
glycoprotein (Kawana et al., 2007). Keratin 8 is a key subunit of intermediate filaments
and cleavage of keratin 8 may facilitate chlamydial replication by increasing the
solubility of intermediate filaments (Dong et al., 2004c). Pro-apoptotic BH3-only
proteins are required for apoptosis in response to cytotoxic stimuli or exogenous stress,
and they function by neutralizing their pro-survival counterparts or activating proapoptotic Bcl-2 family members Bax and Bak (Bouillet & Strasser, 2002). Degradation of
BH3-only proteins contributes to chlamydial anti-apoptotic activity which may help
chlamydiae evade CTL-mediated host cell apoptosis induction and, thus, benefit longterm survival of chlamydiae in infected hosts (Pirbhai et al., 2006). CD1d is an MHC-like
glycoprotein that presents lipid antigen to natural killer T cells. Down-regulation of
CD1d may help C. trachomatis escape detection by the host innate immune system
(Kawana et al., 2007).
Previous studies in our laboratory have demonstrated that accumulation of the
host adherens junction molecule nectin-1 is significantly decreased in C. trachomatis
serovar E-infected cervical epithelial cells at a post-transcriptional level (Sun et al., 2008).
Nectin-1, a member of the nectin family, is a Ca2+-independent cell adhesion molecule
(CAM) with three extracellular Ig-like loops, a single transmembrane domain and a
cytoplasmic region (Takai & Nakanishi, 2003). Nectins are intimately involved in
formation of cell-cell adhesions, which subsequently, in cooperation with other CAMs,
function in formation and maintenance of adherens junctions (AJs) and tight junctions
(TJs) between neighboring epithelial cells. Using the nectin-based adhesion system, AJs
stabilize the epithelium and establish apical-basal polarity of epithelial cells. Additionally,
nectins regulate activities of Rho small GTPases and subsequently modulate epithelial
barrier functions through reorganization of the actin cytoskeleton and the integrity of
intercellular junctions (Braga, 2002). Given the broad range of cellular proteins that are
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CPAF targets, we hypothesized that CPAF may degrade nectin-1 in C. trachomatisinfected genital epithelial cells. Because nectin-1 is very important for formation and
maintenance of AJs and TJs in epithelial cell layers, CPAF-mediated nectin-1
degradation could weaken contacts between an infected genital epithelial cell and
adjacent, uninfected cells. This would allow release of the intact, infected cells into
genital tract lumen, facilitating chlamydial dissemination within genital tract and aiding
establishment of ascending genital tract infection.
Materials and methods
Cell culture and chlamydial infection.
HeLa cells, a human cervical adenocarcinoma epithelial cell line (ATCC No.
CCL2), were maintained at 37 °C in Minimal Essential Medium (MEM, Gibco) with
Earle's salts and L-glutamine supplemented with 10 % fetal calf serum (Atlanta
Biologicals) in an atmosphere of 5 % CO2 and 95 % humidified air. C. trachomatis
LGV2 (L2) was used to generate purified CPAF for cell-free cleavage assays. C.
trachomatis E/UW-5/CX was used for the rest of the experiments. Standardized inocula
of C. trachomatis E were propagated in McCoy cells as previously described (Wyrick et
al., 1996; Zhong et al., 1988). C. trachomatis was used to infect HeLa cells as described
previously (Sun et al., 2008). Unless otherwise indicated, a multiplicity of infection (MOI)
of 1 was used.
Indirect immunofluorescence assay.
HeLa cells were cultured on glass coverslips in 24-well plates overnight and then
either mock- or C. trachomatis E-infected as described (Sun et al., 2008). After various
time periods, the samples were fixed with 100% pre-cooled methanol at −20 °C for
10 min, followed by a brief rinse with 1x PBS. Fixed cells were then blocked for 45 min
at 25 °C in 1x PBS containing 15 % FBS. After blocking, some fixed samples were
incubated with anti-nectin-1 CK6 (1:50 dilution, sc-21722, Santa Cruz Biotechnology)
and anti-C. trachomatis major outer membrane protein (MOMP; 1:200 dilution,
B65266G, Meridian Life Sciences). The other fixed samples were incubated with either
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anti-CPAFn (1:10 dilution, recognizing N terminus fragment of CPAF, a kind gift from
Dr. G.M. Zhong, University of Texas, San Antonio, TX) or anti-MOMP antibodies.
These incubations were carried out for 1 h at 25 °C. Samples were then stained with
Alexa fluor 488 donkey anti-mouse IgG (1:1000 dilution for nectin-1 and 1:500 dilution
for CPAFn, A21202, Invitrogen) or Texas red-conjugated donkey anti-goat IgG (1:200
dilution, 59820, Jackson ImmunoResearch Laboratories) for 1 h at 25 °C. Between
incubations, the samples were washed twice with 1x PBS. After the final washes, the
samples were rinsed with distilled H2O and mounted onto a glass slide using mounting
medium (M01, Biomeda Corp). The following controls were included to confirm the
specificity of nectin-1 or CPAF staining: i) primary antibody alone and ii) secondary
antibody alone. Images were captured at 400 x using a Zeiss Axiovert S100 inverted
microscope and Axiocam camera. Alexa fluor 488-labeled cells were photographed using
a FITC-band pass filter; Texas red-labeled cells were photographed using a Rhodaminelong pass filter. Color images were converted to grayscale for publication using Adobe
Photoshop.
Western blotting.
Monolayers of HeLa cells were lysed and denatured as described by Deka et al.
(Deka et al., 2006). The Western blot assays were performed as described previously
(Sun et al., 2008). Briefly, samples were quantified and normalized for total protein
content by SDS-polyacrylamide gel electrophoresis (PAGE) followed by SYPRO Ruby
staining (BioRad) according to the manufacturer’s instructions. Samples were diluted to
identical concentrations, requantified as above to confirm that the relative concentration
were the same and subjected to SDS-PAGE and Western blotting (Deka et al., 2006).
Primary antibodies used for Western blotting included mouse monoclonal anti-nectin-1
CK6 (1:200 dilution), mouse monoclonal anti-β-actin (1:5000 dilution, MAB1501,
Chemicon), mouse monoclonal anti-CPAFn (1:1000 dilution), mouse monoclonal anticytokeratin-8 (1:5000 dilution, C-5301, Sigma), and goat polyclonal anti-MOMP (1:5000
dilution). Primary antibody binding was detected with corresponding secondary
antibodies conjugated to horseradish peroxidase. Specific bands were quantified using an
FX phosphorimager and Quantity One V2.5.0 software (Bio-Rad). To control for small
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variations in cell number and gel loading between sample lanes, nectin-1 quantity in each
sample was normalized (Deka et al., 2006; Sun et al., 2008) to the amount of β-actin
protein detected in that same lane. Previous studies from our and other laboratories have
demonstrated that β-actin protein accumulation is not altered by chlamydial infection and,
therefore, makes an ideal internal control (Deka et al., 2006)
In vivo proteasome inhibitor treatment.
Monolayers of HeLa cells were either mock- or C. trachomatis E-infected. At 24
h post infection (hpi), either dimethyl sulfoxide (DMSO, diluent control), lactacystin (30
µM in DMSO, no. 426102, Calbiochem) or MG132 (30 µM in DMSO, no. 474790,
Calbiochem) was added to the cell cultures as indicated. Cell lysates were collected at 48
hpi and processed for Western blot analyses using anti-nectin-1 and anti-β-actin
antibodies. Duplicate cell cultures were assayed using the live/dead assay kit (Molecular
Probes) to assure that any decrease in protein expression observed is not due to toxicity
of the inhibitors.
Cell-free cleavage assays.
The cell-free cleavage assays were carried out as previously described (Zhong et
al., 2001). Briefly, cytosolic extracts (CE) containing target proteins keratin 8 and nectin1 were prepared and used as substrate. The enzyme sources included C. trachomatis L2infected HeLa cell cytosolic extracts (L2S100) containing natural CPAF, a functional
recombinant GST-CPAFwt fusion protein, and the inactive recombinant GST-CPAFD502A
mutant at the concentrations listed in the Figure 5 legend (kind gifts from Dr. G. M.
Zhong, University of Texas, San Antonio, TX). The cytosolic extracts were made as
described (Dong et al., 2004c) by extracting 1x107 mock- or C. trachomatis-infected
HeLa cells with 1 ml of a buffer containing 1 % NP-40, 0.5 % Triton X-100 and 150 mM
NaCl in 50 mM Tris (pH 8.0) plus a protease inhibitor cocktail (Sigma). The enzyme was
mixed with the substrate in the presence or absence of inhibitor lactacystin (Calbiochem).
All reactions were carried out at 37 °C for 1.5 h and then subjected to Western blot
analyses using anti-nectin-1 and anti-keratin 8 antibodies.
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Statistical analyses.
All experiments were repeated three times and each repeat contained three
biological replicates, with exception of cell-free cleavage assays which were repeated
twice. Statistical analyses were performed using Microsoft Excel. A two-sample t test for
independent samples was used for comparison of means; p-values ≤ 0.05 were considered
significant.
Results
Nectin-1 down-regulation is C. trachomatis concentration-dependent.
Previous studies in our laboratory demonstrated that host nectin-1 accumulation
was decreased by up to 85 % in C. trachomatis-infected HeLa cells. Nectin-1 downregulation also required active C. trachomatis protein synthesis and replication (Sun et al.,
2008). The obvious next question was: does a chlamydial factor down-regulate nectin-1
in infected cells? Previous infection studies (Sun et al., 2008) were performed at 1 MOI,
which infects 80-90% of HeLa cells in monolayer culture. To determine whether nectin-1
was down-regulated in a dose-response manner, triplicate monolayers of HeLa cells were
either mock-infected or infected with different concentrations of C. trachomatis E as
indicated. Cell lysates were collected at 60 hpi and processed for SDS-PAGE analyses
(Fig. 3.1A, B). Duplicate gels were either Sypro Ruby stained for total protein
quantification (data not shown) or Western blotted (Fig. 3.1A) using anti-nectin-1 CK6
mAb or anti-β-actin mAb, as described previously (Deka et al., 2006). Nectin-1 bands
were quantified, normalized to the β-actin internal control protein, and plotted in Fig.
3.1B. As shown in Fig. 3.1A, compared to mock-infected HeLa cell cultures, nectin-1
accumulation was significantly reduced in HeLa cell cultures infected with C.
trachomatis at an MOI of 1 or 0.5 inclusion forming units/cell. In contrast, infection with
lower quantities of C. trachomatis (0.25 and 0.125 MOI) did not significantly reduce
nectin-1 accumulation. These data clearly demonstrate that nectin-1 down-regulation
within infected cells is C. trachomatis concentration-dependent.
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Figure 3.1 Nectin-1 down-regulation is C. trachomatis concentration-dependent. (A)
HeLa cells were either mock-infected or infected with different concentrations of C.
trachomatis serovar E. Cell lysates were collected at 60 hpi and Western blotted using
anti-nectin-1 (CK6) and anti-β-actin. (B) Nectin-1 bands were quantified and normalized
to the β-actin internal control and plotted. Results are expressed as the mean ± SEM of
three biological replicates. Those data points significantly different from mock-infected
controls are indicated by asterisks (P ≤ 0.05). (C) HeLa cells were cultured on coverslips
and C. trachomatis serovar E-infected at 0.25 MOI. After 48 h, cells were fixed and
subjected to IFA with nectin-1 and MOMP antibodies. Images were captured at 400 x.
All data shown are representative of three independent experiments.

67

To confirm that nectin-1 was decreased only in C. trachomatis-infected cells, we
employed indirect immunofluorescence (IFA) methodology. HeLa cells were cultured on
coverslips and C. trachomatis-infected at an MOI of 0.25 to assure that both uninfected
and infected cells would be visible within a single microscopic field. After 48 h, cells
were fixed and double-stained with nectin-1 and MOMP specific antibodies. As expected,
MOMP was detected in a small number of C. trachomatis-infected HeLa cells (Fig. 3.1C,
right panel, white arrows). Interestingly, nectin-1 was visible in uninfected cells but was
not observed in C. trachomatis-infected HeLa cells (Fig. 3.1C, left panel, white arrows).
These data indicate that nectin-1 accumulation was only decreased in C. trachomatisinfected HeLa cells.
The half-life of nectin-1 in C. trachomatis-infected cells is much shorter than that
observed in mock-infected cells.
To determine whether nectin-1 might be subject to C. trachomatis-mediated
proteolytic degradation, we next determined the half-life of nectin-1 in mock- and C.
trachomatis-infected HeLa cells. Triplicate monolayers of HeLa cells were either mockor C. trachomatis-infected at an MOI of 1 and then incubated in growth medium plus 2
µg/ml cycloheximide, which halts eukaryotic but not C. trachomatis protein synthesis.
Pulse chase experiments in which HeLa cells were incubated in 35S-methiononecontaining medium demonstrated that host protein synthesis is inhibited by >95% under
these conditions {(Deka et al., 2007) and unpublished results}. Previous studies in our
laboratory demonstrated that C. trachomatis infection first significantly reduced nectin-1
accumulation at 36 hpi. The observed reduction was maximal at 60 hpi (Sun et al., 2008).
Therefore, cell lysates were collected for half-life analyses beginning at 36 hpi (middevelopment) and extending into the late-developmental cycle (50 and 57 hpi). Samples
were Western blotted (Fig. 3.2A) and both nectin-1 and β-actin bands were quantified
and plotted. These plots were subsequently used to calculate the half-life of each protein
in mock- and C. trachomatis-infected cells (Fig. 3.2B, C). The half-life of nectin-1 in C.
trachomatis-infected cells was much shorter (~ 7 h) than that observed in mock-infected
cells (> 62 h; data not shown). These data strongly suggest that nectin-1 is downregulated by proteolytic degradation in C. trachomatis-infected cells.
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Figure 3.2 The half-life of nectin-1 in C. trachomatis-infected cells is much shorter than
that observed in mock-infected cells. HeLa cells were mock- or C. trachomatis-infected
at 1 MOI with addition of 2 µg/ml cycloheximide. Cell lysates were collected at 36, 43,
50 and 57 hpi and processed for Western blot analysis as described (Fig. 3.2A). Nectin-1
and β-actin bands were plotted in Fig. 3.2B and C using Minitab 15 statistical software.
The half-life of nectin-1 in mock- or C. trachomatis-infected cells was calculated from
the plots in Fig. 3.2B and C, respectively. The means of three biologic replicates from
three independent experiments are shown.
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CPAF expression correlates with C. trachomatis infection time-dependent cleavage of
nectin-1.
Published studies and the data presented above suggested that a previously
identified chlamydial protease (CPAF) might be responsible for cleaving nectin-1. To test
this possibility, we first examined whether CPAF expression kinetics correlate to the
timing of nectin-1 cleavage in C. trachomatis-infected cells. HeLa cells were either
mock- or C. trachomatis-infected and duplicate cell cultures were collected at 0 and 24
hpi (early development), 36 hpi {mid-development when significant nectin-1 degradation
is first observed (Sun et al., 2008)} as well as at 48 and 60 hpi (late development). Cells
were either: i) fixed for IFA (Fig. 3.3A) and stained with anti-CPAFn and anti-MOMP or
ii) processed for Western blotting (Fig. 3.3B). Western blots were probed using: i) antiCPAFn, ii) anti-nectin-1 CK6, iii) anti-MOMP and iv) anti-β-actin. As previously
observed (Sun et al., 2008), C. trachomatis infection significantly decreased nectin-1
accumulation from 36 to 60 hpi (Fig. 3.3B). CPAF was first detected at 24 hpi by IFA
(Fig. 3.3A) and 36 hpi by Western blotting (Fig. 3.3B); with maximal expression at 60
hpi. These data indicate that CPAF expression within infected cells correlates well with
the timing of nectin-1 cleavage.
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Figure 3.3 CPAF expression correlates with the C. trachomatis infection time-dependent
cleavage of nectin-1. Duplicate cell cultures were collected at 0, 24, 36, 48 and 60 hpi
and either fixed for IFA by staining with anti-CPAFn or anti-MOMP (A) or processed for
Western blot analyses using: (i) anti-CPAFn, (ii) anti-nectin-1 (CK6), (iii) anti-MOMP
and (iv) anti-β-actin (B). IFA images were captured at 400×. Phase contrast images of
stained and non-stained cells are also shown. The data shown are representative of three
independent experiments.
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Nectin-1 down-regulation in C. trachomatis-infected cells is inhibited by the proteasome
inhibitor lactacystin but not by MG132.
The proteolytic activity of CPAF is inhibited by lactacystin, an irreversible
proteasome inhibitor, but not by the similar proteosomal inhibitor MG132 (Zhong et al.,
2001). Therefore, we examined nectin-1 accumulation in C. trachomatis-infected HeLa
cells exposed to either lactacystin or MG132. Triplicate monolayers of HeLa cells were
either mock- or C. trachomatis-infected. At 24 hpi, growth medium plus either DMSO
(diluent control), lactacystin (30 µM in DMSO) or MG132 (30 µM in DMSO) was added
to each culture as indicated in Fig 3.4A. Cell lysates were collected at 48 hpi and
processed for Western analyses (Fig. 3.4A). Nectin-1 bands were quantified, normalized
to the β-actin control and plotted in Fig. 3.4B. As expected, nectin-1 accumulation was
significantly decreased in C. trachomatis-infected and C. trachomatis plus DMSOinfected samples. Notably, down-regulation of nectin-1 was blocked by lactacystinexposure but not by MG132 (Fig. 3.4B), strongly suggesting that CPAF, rather than the
host proteosome, mediates the observed down-regulation of nectin-1 in C. trachomatisinfected HeLa cells.
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Figure 3.4 Down-regulation of nectin-1 in C. trachomatis-infected HeLa cells is inhibited
by the cytosolic proteasome inhibitor lactacystin but not by MG132. HeLa cells were
either mock- or C. trachomatis-infected as described in Fig. 3.2. DMSO (diluent control),
lactacystin (30 µM) or MG132 (30 µM) was added to cell cultures at 24 hpi. Cell lysates
were collected at 48 hpi and processed for Western blot analyses as described. Nectin-1
bands were quantified, normalized to the β-actin internal control and plotted in Fig. 3.4B.
Results are expressed as the mean ± SEM of three biological replicates. Those data
significantly different from the mock-infected controls are indicated by asterisks (P ≤
0.05). All data are representative of three independent experiments.

CPAF is sufficient for nectin-1 degradation in a cell-free assay.
To evaluate whether CPAF alone is sufficient to degrade nectin-1 in C.
trachomatis-infected cells, functional recombinant GST-CPAFwt fusion protein purified
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from E. coli was used to cleave nectin-1 in cell-free, in vitro cleavage assays (Fig. 3.5).
As a positive control for CPAF activity, the blots were also probed for keratin 8, which is
degraded by both natural CPAF present in C. trachomatis L2-infected cell cytosolic
extract (L2S100) and the GST-CPAFwt fusion protein (Dong et al., 2004a). Notably,
L2S100 (a kind gift from Dr. G. Zhong) degraded both nectin-1 and keratin 8 in these
assays (Fig. 3.5, lane 2). As expected, degradation of nectin-1 and keratin 8 by L2S100
extract was reduced when lactacystin was added (Fig. 3.5, lane 3). More importantly,
purified recombinant GST-CPAFwt protein (a kind gift from Dr. G. Zhong) also cleaved
nectin-1 in a concentration dependent manner (Fig. 3.5, lanes 4-6). Again, lactacystin
reduced GST-CPAFwt activity on nectin-1 (Fig. 3.5, lane 7), as previously observed in
vivo. Collectively, these observations indicate that nectin-1 degradation is not mediated
by the host proteosome or proteolytic enzymes and demonstrate that CPAF activity is
sufficient for the nectin-1 degradation observed in C. trachomatis-infected HeLa cells.

H2O

20

15

14

20

20

20

19

20

20

20

19

L2S100

-

5

5

-

-

-

-

-

-

-

-

GST-CPAFwt
GST-CPAFD502A

-

-

-

1

4

15

15

-

-

-

-

-

-

-

-

-

-

-

1

4

15

15

Lactacystin (10mM)

-

-

1

-

-

-

1

-

-

-

1

CE

10

10

10

10

10

10

10

10

10

10

10

kDa

1

2

3

4

5

6

7

8

9

10

11

100 75 -

(Unit: µl)

- Nectin-1
(75 kDa)

50 75 -

- Keratin 8
(52 kDa)

50 -

Keratin 8
fragments

37 -

Figure 3.5 CPAF is sufficient for degrading nectin-1. A cell-free cleavage assay was
performed using: i) C. trachomatis serovar L2-infected cell cytosolic extract (L2S100)
which contains natural CPAF (0.0235 µM), ii) a functional recombinant GST-CAPFwt
fusion protein expressed in E. coli and iii) the E. coli-expressed, recombinant inactive
GST-CPAFD502A mutant. The components in each reaction, as well as the amount of each
component, are listed above each lane in Fig. 3.5. Reactions in lanes 4 and 8 contained
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0.33 µmol of either GST-CAPFwt or GST-CPAFD502A. Other reactions contained either
1.33 µmol (lanes 5 and 9) or 5 µmol (lanes 6, 7, 10 and 11) respectively. Cytosolic
extract (CE) from mock-infected HeLa cells provides the substrates for CPAF-cleavage,
including nectin-1 and keratin-8. All reactions were incubated at 37 °C for 1.5 h and then
subjected to Western blot analyses using anti-nectin-1 (CK6) and anti-keratin-8. The data
are representative of two independent experiments.

Discussion
Chlamydiae are obligate intracellular bacteria that progress through their
developmental cycle within an inclusion in the eukaryotic host cell. In order to survive
and successfully replicate, chlamydiae have evolved a variety of strategies to cope with
the harsh intracellular environment, such as avoiding fusion with lysosomes (Ojcius et al.,
1998), prevention of host cell apoptosis (Fan et al., 1998), and altering host cell signal
transduction (Xia et al., 2003). A chlamydia-secreted protease, termed CPAF, degrades a
number of host cell proteins during chlamydial infection, including transcription factors
RFX5 and USF-1, keratin 8, pro-apoptotic BH-3 only proteins, and CD1d glycoprotein.
Thus, CPAF activity may contribute to chlamydial anti-apoptotic activity, evasion of host
immune detection and modification of host cell cytoskeleton (Dong et al., 2004c;
Kawana et al., 2007; Pirbhai et al., 2006; Zhong et al., 2000).
Previous studies in our laboratory demonstrated that nectin-1, a key host cellular
adhesion protein, is significantly down-regulated in C. trachomatis-infected HeLa cells at
a post-transcriptional level (Sun et al., 2008). In the current study, we focused on
elucidating the molecular mechanism(s) by which chlamydiae down-regulate nectin-1.
Collectively, our observations have led us to conclude that CPAF is both necessary and
sufficient for nectin-1 degradation. Interestingly, several studies of other human
pathogens suggest that disruption of cell-cell junctions is an important strategy to help
intracellular pathogens to spread from cell to cell. Helicobacter pylori, a major etiological
agent in peptic ulcer disease, decreases host cell E-cadherin, an essential protein for
maintenance of AJs (Terres et al., 1998), and alters distribution of ZO-1, a key TJ
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scaffolding protein (Krueger et al., 2007). Shigella flexneri, an important cause of acute
bacillary dysentery in humans, reduces functional components of TJs, including ZO-1,
ZO-2, and claudin-1 in infected intestinal epithelial cells (Sakaguchi et al., 2002). These
alterations, triggered by pathogen infection, are associated with decreased transepithelial
electrical resistance (TER) and increased paracellular permeability, which subsequently
result in elongated host cell phenotype and increased migration. As described before,
nectin-1 is a key component of AJs and plays critical roles in formation and maintenance
of AJs and TJs. Down-regulation of nectin-1 by CPAF would be expected to reduce the
integrity and strength of AJs and TJs, leading to loosening of adjacent cell-cell junctions.
Relaxation of cell:cell adhesions may allow C. trachomatis to rearrange host cell
structures required for inclusion enlargement or for EB release at the end of the
developmental cycle. On the other hand, disruption of cell-cell junctions may facilitate C.
trachomatis dissemination within infected host genial tract by allowing release of intact C.
trachomatis-infected cells from epithelial monolayers. This prediction is consistent with
previous observations that cervical epithelial cells separate from each other as a
consequence of C. trachomatis infection (Prozialeck et al., 2002). Released infected cells
could then drift away from original infection sites in the genital mucus and establish
infection in new locations, which may help explain the phenomenon of chronic,
ascending infection from the lower to the upper human genital tract.
Acknowledgments
This work was supported by East Tennessee State University (ETSU) research
development committee (RDC) grant 04-024M to R.V.S., the James H. Quillen College
of Medicine and the Department of Microbiology. A special thanks to the ETSU School
of Graduate Studies for its graduate research grant award to J. Sun. The authors would
like to thank Dr. Guangming Zhong (University of Texas Health Science Center at San
Antonio) for his kind gifts of anti-CPAFn antibody, cytosolic extract L2S100, and
purified recombinant GST-CPAFwt and GST-CPAFD502A and Ding Chen (University of
Texas Health Science Center at San Antonio) for her helpful technical assistance.

76

References
Bouillet, P. & Strasser, A. (2002). BH3-only proteins - evolutionarily conserved
proapoptotic Bcl-2 family members essential for initiating programmed cell death. J Cell
Sci 115, 1567-1574.
Braga, V. M. (2002). Cell-cell adhesion and signalling. Curr Opin Cell Biol 14, 546-556.
Darville, T. (2000). Chlamydia spp. In persistent Bacterial Infections, pp. 229-261.
Edited by J. P. Nataro, M. J. Blazer and S. Cunningham-Rundles. Washington, DC:
America Society for Microbiology.
Deka, S., Vanover, J., Dessus-Babus, S., Whittimore, J., Howett, M. K., Wyrick, P. B.
& Schoborg, R. V. (2006). Chlamydia trachomatis enters a viable but non-cultivable
(persistent) state within herpes simplex virus type 2 (HSV-2) co-infected host cells. Cell
Microbiol 8, 149-162.
Dong, F., Pirbhai, M., Zhong, Y. & Zhong, G. (2004a). Cleavage-dependent activation
of a chlamydia-secreted protease. Mol Microbiol 52, 1487-1494.
Dong, F., Sharma, J., Xiao, Y., Zhong, Y. & Zhong, G. (2004b). Intramolecular
dimerization is required for the chlamydia-secreted protease CPAF to degrade host
transcriptional factors. Infect Immun 72, 3869-3875.
Dong, F., Su, H., Huang, Y., Zhong, Y. & Zhong, G. (2004c). Cleavage of host keratin
8 by a Chlamydia-secreted protease. Infect Immun 72, 3863-3868.
Fan, P., Dong, F., Huang, Y. & Zhong, G. (2002). Chlamydia pneumoniae secretion of
a protease-like activity factor for degrading host cell transcription factors required for
major histocompatibility complex antigen expression. Infect Immun 70, 345-349.
Fan, T., Lu, H., Hu, H., Shi, L., McClarty, G. A., Nance, D. M., Greenberg, A. H. &
Zhong, G. (1998). Inhibition of apoptosis in chlamydia-infected cells: blockade of
mitochondrial cytochrome c release and caspase activation. J Exp Med 187, 487-496.
Kawana, K., Quayle, A. J., Ficarra, M. & other authors (2007). CD1d degradation in
Chlamydia trachomatis-infected epithelial cells is the result of both cellular and
chlamydial proteasomal activity. J Biol Chem 282, 7368-7375.
Krueger, S., Hundertmark, T., Kuester, D., Kalinski, T., Peitz, U. & Roessner, A.
(2007). Helicobacter pylori alters the distribution of ZO-1 and p120ctn in primary human
gastric epithelial cells. Pathol Res Pract 203, 433-444.

77

Ojcius, D. M., Bravo de Alba, Y., Kanellopoulos, J. M., Hawkins, R. A., Kelly, K. A.,
Rank, R. G. & Dautry-Varsat, A. (1998). Internalization of Chlamydia by dendritic
cells and stimulation of Chlamydia-specific T cells. J Immunol 160, 1297-1303.
Pirbhai, M., Dong, F., Zhong, Y., Pan, K. Z. & Zhong, G. (2006). The secreted
protease factor CPAF is responsible for degrading pro-apoptotic BH3-only proteins in
Chlamydia trachomatis-infected cells. J Biol Chem 281, 31495-31501.
Prozialeck, W. C., Fay, M. J., Lamar, P. C., Pearson, C. A., Sigar, I. & Ramsey, K.
H. (2002). Chlamydia trachomatis disrupts N-cadherin-dependent cell-cell junctions and
sequesters beta-catenin in human cervical epithelial cells. Infect Immun 70, 2605-2613.
Sakaguchi, T., Kohler, H., Gu, X., McCormick, B. A. & Reinecker, H. C. (2002).
Shigella flexneri regulates tight junction-associated proteins in human intestinal epithelial
cells. Cell Microbiol 4, 367-381.
Sun, J., Kintner, J. & Schoborg, R. V. (2008). The host adherens junction molecule
nectin-1 is downregulated in Chlamydia trachomatis-infected genital epithelial cells.
Microbiology 154, 1290-1299.
Takai, Y. & Nakanishi, H. (2003). Nectin and afadin: novel organizers of intercellular
junctions. J Cell Sci 116, 17-27.
Terres, A. M., Pajares, J. M., O'Toole, D., Ahern, S. & Kelleher, D. (1998). H pylori
infection is associated with downregulation of E-cadherin, a molecule involved in
epithelial cell adhesion and proliferation control. J Clin Pathol 51, 410-412.
Wyrick, P. B., Gerbig, D. G., Jr., Knight, S. T. & Raulston, J. E. (1996). Accelerated
development of genital Chlamydia trachomatis serovar E in McCoy cells grown on
microcarrier beads. Microb Pathog 20, 31-40.
Wyrick, P. B. (2000). Intracellular survival by Chlamydia. Cell Microbiol 2, 275-282.
Xia, M., Bumgarner, R. E., Lampe, M. F. & Stamm, W. E. (2003). Chlamydia
trachomatis infection alters host cell transcription in diverse cellular pathways. J Infect
Dis 187, 424-434.
Zhong, G., Fan, T. & Liu, L. (1999). Chlamydia inhibits interferon gamma-inducible
major histocompatibility complex class II expression by degradation of upstream
stimulatory factor 1. J Exp Med 189, 1931-1938.
Zhong, G., Liu, L., Fan, T., Fan, P. & Ji, H. (2000). Degradation of transcription factor
RFX5 during the inhibition of both constitutive and interferon gamma-inducible major
histocompatibility complex class I expression in chlamydia-infected cells. J Exp Med 191,
1525-1534.

78

Zhong, G., Fan, P., Ji, H., Dong, F. & Huang, Y. (2001). Identification of a chlamydial
protease-like activity factor responsible for the degradation of host transcription factors. J
Exp Med 193, 935-942.
Zhong, G. M., Peterson, E. M., Czarniecki, C. W. & de la Maza, L. M. (1988).
Recombinant murine gamma interferon inhibits Chlamydia trachomatis serovar L1 in
vivo. Infect Immun 56, 283-286.

79

CHAPTER 4

NECTIN-1 IS REQUIRED FOR HERPES SIMPLEX VIRUS (HSV) CO-INFECTIONINDUCED CHLAMYDIA TRACHOMATIS PERSISTENCE

Jingru Sun1, Jennifer Kintner1, Judy Whittimore1 and Robert V. Schoborg1*

1

Department of Microbiology, James H. Quillen College of Medicine, East Tennessee
State University, Johnson City, TN 37614

* Corresponding Author. Mailing address: Department of Microbiology, Box 70579,
James H. Quillen College of Medicine, Johnson City, TN 37614-0579. Phone: (423) 4396295. Fax: (423) 439-8044. E-mail: schoborg@etsu.edu

Running title: necint-1 is required for HSV co-infection-induced C. trachomatis
persistence.
Keywords: Chlamydia trachomatis, HSV, Co-infection, Nectin-1.

Abbreviations: EB, elementary body; RB, reticulate body; HSV-1, 2, herpes simplex
virus type 1, 2; HVEM, herpes viral entry mediator; IFN, interferon; MOMP, major
outer-membrane protein; STD, sexually transmitted disease; 3-O-S-HS, 3-O sulfated
heparan sulfate; TNF, tumor necrosis factor; gD, glycoprotein D; IFU, inclusion-forming
unit; CPAF, chlamydial protease/proteasome-like activity factor; m.o.i, multiplicity of
infection; h.p.i, hours post infection.

80

Summary
Studies from our laboratory indicate that during Chlamydia trachomatis/HSV coinfection, the chlamydiae become persistent. Also, interaction of purified, recombinant
HSV-2 glycoprotein D (gD) with the host cell surface mediates this effect in the absence
of viral infection. Therefore, we hypothesize that gD/host cell surface receptor interaction
initiates a host HeLa cell response that restricts chlamydial development. During viral
entry, HSV gD interacts with one of 4 host co-receptors: HVEM (herpes virus entry
mediator), nectin-1, nectin-2, and 3-O-sulfated heparan sulfate. HVEM and nectin-1 are
high-affinity entry receptors for both HSV-1 and HSV-2. Nectin-2 mediates HSV-2 entry
with high efficiency but is essentially inactive for HSV-1, while 3-O-sulfated heparan
sulfate facilitates HSV-1, but not HSV-2, entry. Western blot and RT-PCR analyses
demonstrate that HeLa and HEC-1B cells express nectin-1 and nectin-2, but no HVEM.
Because both HSV-1 and HSV-2 trigger persistence, these data suggest that, of the coreceptors, nectin-1 is the most likely involved. Interestingly, previously published studies
indicate that nectin-1 is strongly down-regulated by 36 hours post-infection (h.p.i) in C.
trachomatis-infected HeLa cells. Similarly, Western blot analyses demonstrate that
nectin-1 is decreased by 68% in C. muridarum-infected HeLa cells by 24 h.p.i. Notably,
HSV co-infection experiments using either C. muridarum or C. trachomatis indicate that
the chlamydae become resistant to the effects of viral co-infection at 24 and 36 h.p.i,
respectively. These data suggest that HSV co-infection can not interfere with chlamydial
development in the absence of nectin-1. Co-infection experiments using nectin-1-specific
HSV-1 mutants suggest that nectin-1 is, indeed, required for persistence induction.
Additional studies in single co-receptor-expressing CHO cells demonstrate that, despite
the fact that HSV-1 enters both HVEM and nectin-1-expressing cells, viral co-infection
reduces chlamydial infectivity only in the CHO-nectin-1 cell line. These data confirm
that virus/nectin-1 interaction is sufficient for chlamydial persistence induction. Although
nectin-1 ligation is known to activate the small G protein, Cdc42, pull-down assays
indicate that Cdc42 is not activated in co-infected HeLa cells. Thus, we hypothesize that
this anti-chlamydial response is mediated through an as yet uncharacterized nectin-1activated host signaling pathway.
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Introduction
According to the Centers for Disease Control and Prevention, sexually transmitted
diseases (STDs) are among the most common infections in the United States.
Approximately 19 million new STDs cases occur each year in the United States, almost
half of them among people ages 15 to 24 (Weinstock et al., 2004). Two of the most
commonly reported STD agents in the United States are Chlamydia trachomatis (serovars
D-K; 4,000,000 new cases/year) and Herpes Simplex Virus (primarily HSV-2; 200,000500,000 new cases/year) (Bulter, 1997).
C. trachomatis is a Gram-negative, obligate intracellular bacterium that frequently
causes chronic, asymptomatic genital infections. Such infections can result in
complications such as epididymitis, prostatitis, ectopic pregnancy, salpingitis, and
infertility (Darville, 2000a). All chlamydiae share a unique biphasic developmental cycle,
alternating between two morphologically distinct forms. The extracellular, infectious but
metabolically inert form (the elementary body or EB, 0.3µm diameter) attaches to and
enters mucosal epithelial cells via receptor mediated endocytosis (Wyrick, 2000).
Following the fusion of EB-containing endosomes, EBs develop into larger (1µm
diameter), metabolically active but non-infectious reticulate bodies (RBs). Using ATP
and metabolites from the host cell, RBs grow and divide within an enlarged endosomal
sac (the inclusion). After 8-12 rounds of replication, the RBs mature into infectious EBs,
which are released from the host cell (Wyrick, 2000).
When developing chlamydiae are exposed to unfavorable environmental
conditions, they deviate from the normal developmental cycle into a viable but noninfectious state termed persistence (Hogan et al., 2004), where they can remain for
months (Galasso & Manire, 1961). Several studies have demonstrated that under
appropriate circumstances, chlamydial persistence may occur in vivo (Bragina et al., 2001;
Dean et al., 2000; Fortenberry et al., 1999; Gerard et al., 2001; Patton et al., 1994).
Known inducers include IFN-γ, TNF-α and penicillin-exposure as well as amino acid,
glucose and iron deprivation (Beatty et al., 1994a; Darville et al., 2000; Gerard et al.,
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2001; Raulston, 1997). Persistent chlamydiae continue to synthesize unprocessed 16S
rRNA and replicate chromosomes but fail to divide (Gerard et al., 1998; Gerard et al.,
2001). At the ultrastructural level, persistent chlamydiae appear as swollen, misshapen,
diffuse RBs with increased membrane blebbing. Notably, because they are viable,
persistent chlamydiae have ability to re-enter and complete the normal developmental
cycle once the persistence “inducer” is removed.
Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) are members of the viral
family Herpesviridae. The HSV virion has a large double-stranded DNA genome that is
packed within a capsid shell, which is in turn coated with a protein layer (the tegument)
and an envelope composed of lipids and more than a dozen viral glycoproteins (Spear &
Longnecker, 2003). Though HSV-1 causes some genital infections, HSV-2 is the major
causative agent of genital herpes. Initial HSV-2 infection usually occurs on the mucous
membranes and skin surrounding the genitals, where painful skin vesicles are formed.
The virus subsequently establishes life-long latent infection in the sacral ganglia. Viral
replication and symptomatic infection can be periodically reactivated, during which
lesions and virions are present (Corey et al., 1983).
Entry of HSV into cells is initiated when the virion binds to cell surface receptor
heparan sulfate using the viral envelope proteins gC and/or gB. The viral gD envelope
glycoprotein then interacts with one of 4 cellular co-receptors, including HVEM (herpes
virus entry mediator), nectin-1, nectin-2 or 3-O sulfated heparan sulfate (3-O-S-HS)
(Spear, 2004). HVEM is a member of the tumor necrosis factor (TNF) receptor family
which is present on lymphoid and epithelial cells and serves as a co-receptor for both
HSV-1 and HSV-2. Nectin-1 and -2 are cell adhesion molecules belonging to the
immunoglobulin superfamily which play important roles in the formation of adhesion and
tight junctions (Sakisaka & Takai, 2004). Nectin-1 mediates entry of both HSV-1 and
HSV-2 equally well, while nectin-2 facilitates HSV-2 entry but is nearly inactive for
HSV-1. Conversely, 3-O-S-HS primarily mediates HSV-1 entry (Spear, 2004). The
binding of gD to any one of the these co-receptors facilitates the fusion of the viral
envelope with the host cell plasma membrane. Once the viral capsid enters the host cell,
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replication takes place in the nucleus. New virions are assembled in the nucleus and
egress the host cell by vesicular transport (Roizman, 2001a).
Several previous studies from our laboratory demonstrate that HSV-2 superinfection of C. trachomatis serovar E-infected genital epithelial cells induces chlamydial
persistence (Deka et al., 2006). In addition, induction of C. trachomatis persistence by
HSV is neither host cell type nor virus strain specific (Deka et al., 2007). De novo
host/viral protein synthesis and productive HSV replication are not required for
chlamydial persistence induction (Deka et al., 2007). Furthermore, HSV co-infectioninduced chlamydial persistence is not mediated by any previously identified persistence
inducer or anti-chlamydial pathway (Vanover et al., 2008). Unpublished data (Vanover,
2009b) from our laboratory indicate that HSV glycoprotein D (gD) interaction with host
cell surface is sufficient to induce chlamydial persistence. Therefore, we performed coinfections using co-receptor-specific HSV mutants and co-receptor expressing CHO host
cell lines to test the hypothesis that virus interaction with one of the known co-receptors
is sufficient to alter the chlamydial developmental cycle.
Methods
Cells, viruses and chlamydiae.
Chinese hamster ovary (CHO) cell lines including CHO-C8 (containing the
pcDNA3 plasmid vector alone), CHO-HVEM, CHO-nectin-1, and CHO-nectin-2 (kind
gifts from Dr. Patricia Spear, Northwestern University) were used in co-infection
experiments. CHO-C8 cells express cell surface HS but lack all known HSV co-receptors.
HSV-1 KOS binds to CHO-C8 cells, but does not enter, even at multiplicities (10-100
m.o.i) that infect HeLa cells with 100% efficiency (Johnson & Spear, 1989). CHOHVEM, CHO-nectin-1 and CHO-nectin-2 express recombinant HVEM, nectin-1 and
nectin-2, respectively. CHO-HVEM and CHO-nectin-1 are permissive for HSV-1 KOS
entry (Yoon & Spear, 2004). The other cell lines used in the study were HeLa cervical
adenocarcinoma epithelial cells (ATCC No. CCL2) and HEC-1B endometrial epithelial
cells (ATCC No. HTB-113). Wild type HSV strains HSV-2 333 and HSV-1 KOS were
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obtained from Dr. Mary K. Howett (Drexel University) and Dr. Udayasankar
Kumaraguru (East Tennessee State University), respectively. The parental stain HSV-1
KOS/FRT-gD (expressing wild type gD) and the gD amino acid substitution mutants
HSV-1 KOS/FRT-gDG43P, HSV-1 KOS/FRT-gDQ27P and HSV-1 KOS/FRT-gDA3C/Y38C
were obtained from Dr. Patricia Spear (Northwestern University). The parental strain and
all mutants express β-galactosidase (β-gal) activity upon host cell entry (Yoon & Spear,
2004). C. trachomatis E/UW-5/CX was originally obtained from Dr. S.P.Wang and Dr.
C.C.Kuo (University of Washington) and C. muridarum strain Nigg was obtained from
Dr. Roger Rank (University of Arkansas Health Sciences Center).
Co-infection experimental design.
Co-infections were performed as previously described by Deka et al (Deka et al.,
2006). In most experiments, host cells were divided into four groups, 1x106 cells per
60mm culture dish, for mock-infection, chlamydial-infection, HSV-infection, and
chlamydia/HSV double infection. Host cells were infected with a dilution of crude EB
stock (200 µl) calculated to infect > 80% of the cells and with HSV at an m.o.i of 10 (10
PFU/cell). Mock-infected cells were treated similarly except they were exposed to 200 µl
of either 2SPG (0.2 M sucrose, 6 mM NaH2PO4, 15 mM Na2HPO4, 5 mM L-glutamine,
pH 7.2; mock chlamydial infection) or growth medium (mock viral infection).
SDS-PAGE and Western blotting.
Monolayers of host cells were lysed and denatured as previously described (Deka
et al., 2006). The Western blot assays were conducted as described by Sun et al (Sun et
al., 2008). Briefly, samples were quantified using SYPRO Ruby stain (Bio-Rad)
according to the manufacturer’s instructions. Samples were diluted to identical
concentrations, re-quantified to confirm that the relative concentrations were the same
and subjected to SDS-PAGE and Western blotting (Deka et al., 2006). Primary
antibodies used included mouse monoclonal anti-nectin-1 CK6 (1:200 dilution; sc-21722,
Santa Cruz Biotechnology), goat polyclonal anti-chlamydial major outer-membrane
protein (MOMP; 1:5000 dilution; B65266G, BioDesign International), mouse
monoclonal anti-β-actin (1:5000 dilution; MAB1501, Chemicon), goat polyclonal anti-
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nectin-2 (1:1000 dilution; AF2229, R&D systems) and goat polyclonal anti-HVEM (N19) (1:500 dilution; sc-7766, Santa Cruz Biotechnology). Primary antibody binding was
detected with corresponding secondary antibodies conjugated to horseradish peroxidase
and visualized using SuperSignal West Pico reagent (Pierce). Bands of interest were
quantified using an FX phosphorimager and Quantity One V2.5.0 software (Bio-Rad). To
control for small variations in cell number and gel loading between sample lanes, the
nectin-1 quantity in each sample was normalized to the amount of β-actin protein
detected in that same lane (Sun & Schoborg, 2008).
RNA isolation, reverse transcription and RT-PCR.
Total RNA was isolated from experimental samples using the RNeasy Mini
(Qiagen) kit as described previously (Deka et al., 2006). RNA preparations were
quantified by measuring OD at 260 and 280 nm. All samples had OD260/OD280 ratios >
1.9. Agilent bioanalyses also indicated that all RNAs used had a RIN of >9.8. RNA
samples were subjected to reverse transcription as described previously (Deka et al., 2006)
and RT-PCR reactions were subsequently carried out using RT(+) and RT(-) cDNA
reactions as templates, as appropriate. Experimental template cDNAs were diluted from
1/10 to 1/1000 in double-distilled H2O and synthetic control DNA targets were diluted
from 10 to 0.01pg/ml, ensuring that each reaction was quantified in the linear
amplification range. The specific primers and synthetic control DNA targets for HVEM
and nectin-2 were designed using Vector NTI Advance V10 (Invitrogen) and are listed in
Supplementary Table S1. Nectin-1α, -1β and -1γ specific primers and their
oligonucleotide amplification controls were previously described (Sun et al., 2008). Most
reactions were performed using the following cycling conditions (unless otherwise
indicated): 94°C, 1 min; 60°C, 1 min; 72°C, 1 min for 35 cycles. The resulting PCR
products were electrophoresed and quantified as previously described (Sun et al., 2008).
β-galactosidase assay.
This assay was performed as described previously (Montgomery et al., 1996). In
this assay, β-gal expression (and virion entry) is indicated by the formation of an
insoluble blue reaction product. Six hours after HSV infection, cells were washed with
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1x PBS and fixed with 2% formaldehyde/0.2% glutaraldehyde in PBS for 10 min at room
temperature. Following fixation, the cells were washed with 1x PBS and permeablized
with 2 mM MgCl2/0.01% deoxycholate/0.02% NP-40 in PBS for 10 min at room
temperature. The cells were incubated with 0.5 mg/ml X-gal (5-bromo-3-indoyl-β-Dgalactopyranoside) in PBS for at least 1 hour at 37°C. Images were obtained using an
Epson Perfection 3200 Photo Scanner and Photoshop Elements Software.
Chlamydial titration by subpassage.
Chlamydial titrations were conducted as previously described (Deka et al., 2006)
using Pathfinder anti-chlamydial stain (Bio-Rad) to stain chlamydial inclusions formed
from subpassaged EBs. The number of inclusion-forming units (IFU) in the undiluted
inoculum was derived from triplicate counts and expressed as IFU ml-1.
Transmission electron microscopy.
C. trachomatis-infected or C. trachomatis/HSV co-infected HeLa cells were
processed for high-contrast TEM as described (Wyrick, 1994). Counter-stained gold thin
sections were examined using a Tecnai 10 (FEI) transmission electron microscope
operating at 60-80 kV.
HSV-1 plaque assay.
At 20h post HSV-1 infection, cell culture supernatants were collected and
centrifuged at 4000g for 5 min at 4°C to remove cell debris. Plaque assays were
performed on the resulting supernatants as described (Duff & Rapp, 1971). Quadruplicate,
infected cultures were incubated with methylcellulose at 37°C for 72h, followed by
removing methylcellulose and staining with a solution of 5% formaldehyde and 0.5%
crystal violet for 1h. Plates were then washed and plaques were counted. Average plaque
counts from each set of plates were used to calculate the pfu ml-1 present in the original
supernatant.
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Statistical analyses.
Statistical analyses were performed using Microsoft Excel. A two-sample t test
for independent samples was used for comparison of means; p-values ≤ 0.05 were
considered significant.
Results
HeLa and HEC-1B cells express nectin-1 and nectin-2 but not HVEM.
Previous data from our laboratory have demonstrated that HSV-induced
chlamydial persistence occurs in both HeLa and HEC-1B cells (Deka et al., 2007). To aid
in elucidating which, if any, host HSV co-receptors are involved, we first determined
which co-receptors HeLa and HEC-1B cells express. HeLa or HEC-1B cell lysates were
subjected to SDS-PAGE and Western blotted with either HVEM, nectin-1, nectin-2 or βactin antibodies. CHO-HVEM, CHO-nectin-1 and CHO-nectin-2 cell lysates were used
as positive controls, respectively. As shown in Fig. 1(a), both HeLa and HEC-1B cells
express nectin-1 and nectin-2, but not HVEM. As expected, HVEM, nectin-1 and nectin2 are easily detected in the appropriate CHO cell line. These data indicate that the HeLa
and HEC-1B cell lines used in our experiments express nectin-1 and 2, but not HVEM.
Because it is possible that HeLa and HEC-1B cells express only a small quantity
of HVEM that was below the level of Western blot detection, total RNA from HeLa,
HEC-1B, or CHO-HVEM cells was isolated and subjected to RT-PCR using specific
primers for HVEM. In each experiment, a four log dilution series of synthetic control
DNA was used to generate standard curves for amplification. Experimental samples were
only quantified if they fell within the linear range of the PCR. All amplimers were the
expected size (Fig. 1b) and the identity of each was confirmed by DNA sequencing (data
not shown). Amplification products were not observed in template-negative samples (Fig.
1b, lane 6) or in RT(-) controls (data not shown). As shown in Fig. 1(b), CHO-HVEM
cell controls express a large amount of HVEM mRNA (lane 9). However, HVEM
transcript was not observed in either HeLa or HEC-1B samples, even after 38 cycles of
amplification (lanes 7 and 8). Similarly, total RNA from HeLa, HEC-1B and the
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appropriate CHO control cell lines was subjected to RT-PCR using specific primers for
nectin-1α, -1β, -1γ and nectin-2 (see supplementary data, Fig. S1a,b). As expected, both
HeLa and HEC-1B cells express nectin-1 and nectin-2 mRNAs, although in a lower
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Figure 4.1 HeLa and HEC-1B cells express nectin-1 and nectin-2 but not HVEM. (a)
HeLa or HEC-1B cell lysates were subjected to SDS-PAGE and Western blotted with
either HVEM, nectin-1, nectin-2 or β-actin antibodies. CHO-HVEM, CHO-nectin-1 and
CHO-nectin-2 cell lysates were used as positive controls, respectively. (b) Total RNA
from HeLa, HEC-1B or CHO-HVEM cells was isolated and subjected to RT-PCR using
specific primers for HVEM. In each experiment, a four log dilution series of synthetic
control DNA was used to generate standard curves for amplification. Experimental
samples were only quantified if they fell within the linear range of the PCR. The position
of DNA size markers are shown to the left of each gel image in base pairs (bp).
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Collectively, these above data demonstrate that both HeLa and HEC-1B cells
express nectin-1 and nectin-2, but express little or no HVEM. In addition, it has been
demonstrated that anti-HVEM antibodies only had marginal effects on the entry of HSV1 into HeLa cells, suggesting that HVEM is probably not a major receptor mediating
HSV entry into HeLa cells (Montgomery et al., 1996). On the other hand, previous
studies have demonstrated that both HSV-1 and HSV-2 trigger chlamydial persistence
(Deka et al., 2007) and both use HVEM and nectin-1 equally well (Spear, 2004).
Moreover, nectin-2 mediates HSV-2 entry with high efficiency but is nearly inactive for
HSV-1, while 3-O-S-HS facilitates HSV-1, but not HSV-2 entry (Spear, 2004). Thus,
together, these data suggest that, of the co-receptors, nectin-1 is the most likely candidate
involved in HSV-induced chlamydial persistence.
HSV co-infection does not affect the chlamydial developmental cycle in the absence of
nectin-1.
During the process of co-infection studies on C. trachomatis, we examined other
chlamydial species to see whether they also enter persistence in HSV co-infected host
cells. C. muridarum, formerly the mouse pneumonitis biovar of C. trachomatis, naturally
infects only members of the family Muridae (Everett et al., 1999). HeLa cells were either
mock-, HSV-2-, C. muridarum-, or co-infected. To determine the effect of HSV coinfection on C. muridarum development, HeLa cells were infected with C. muridarum for
6h, 12h or 24h, followed by HSV-2 infection. Cells were collected 20h post HSV-2
infection and processed for chlamydial EB titration. As shown in Fig. 2(a), when
compared with chlamydia singly-infected controls, production of infectious EBs was
significantly decreased when HSV-2 was added at 6h and 12h post-chlamydial infection.
In contrast, no significant reduction in chlamydial infectivity was observed when the
virus was added at 24h post-chlamydal infection (Fig. 2a). In addition, the effect of HSV2 on C. muridarum infectivity is greater at 6h than at 12h.
Published data from our laboratory demonstrated that nectin-1 is degraded in C.
trachomatis-infected HeLa cells at 36 to 48 h.p.i (Sun et al., 2008). Based on this
information, we examined C. muridarum-infected HeLa cells to see whether nectin-1
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down-regulation correlates with the time post-infection at which C. muridarum becomes
insensitive to HSV co-infection. HeLa cells were either mock- or C. muridarum-infected.
Cell lysates were collected at 0, 6, 12, 24, 36 h.p.i and Western blotted with (i) antinectin-1, (ii) anti-MOMP, (iii) anti-β-actin. A representative blot is shown in Fig. 2(b);
the quantification of nectin-1 is shown in Fig. 2(c). These data clearly demonstrate that C.
muridarum also degrades nectin-1 and that significant degradation is first observed at 24
h.p.i. Thus, these results suggest that HSV co-infection can not disrupt the normal
chlamydial developmental cycle in the absence of nectin-1.
It is important to note that, in all of our published co-infection experiments using
C. trachomatis, the virus was added at 24 h post-chlamydia infection. Our data indicate
that in C. trachomatis-infected HeLa cultures nectin-1 quantity is essentially unaltered at
24 h.p.i (Sun et al., 2008). Therefore, we also examined whether HSV co-infection can
influence chlamydial development when HSV was added at 36h and 48h post C.
trachomatis-infection, at which times significant nectin-1 down-regulation is observed
(Sun et al., 2008). HeLa cells were either mock-, HSV-2-, C. trachomatis-, or co-infected.
For co-infected HeLa cells, cells were co-infected with HSV-2 either 24h, 36h, or 48h
after addition of the chlamydiae. Cells were collected at 20h post HSV-2 infection and
processed for chlamydial EB titration. As shown in Fig. 2(d), when compared with
chlamydia singly-infected controls, a significant decrease in the production of infectious
EBs occurred in co-infected cells when HSV-2 was added at 24h and 36h but not when
HSV-2 was added at 48h post-chlamydial infection. In addition, the effect of HSV-2 on C.
trachomatis infectivity is greater at 24h than at 36h. These data are consistent with the C.
muridarum results and suggest that nectin-1 is required for HSV co-infection-induced
disruption of the chlamydial developmental cycle.
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Figure 4.2 HSV co-infection does not affect the chlamydial developmental cycle in the
absence of nectin-1. (a) HeLa cells were either mock-, HSV-2-, C. muridarum-, or coinfected. For co-infected HeLa cells, cells were infected with C. muridarum for 6h, 12h
or 24h, followed by HSV-2 infection. Cells were collected 20h post HSV-2 infection and
processed for chlamydial EB titration. Asterisks (*) indicate titres that are significantly
different compared with those from C. muridarum singly-infected cells (P<0.05). (b)
HeLa cells were either mock- or C. muridarum-infected. Cell lysates were collected at 0,
6, 12, 24, 36 h.p.i and Western blotted with (i) anti-nectin-1, (ii) anti-MOMP, (iii) anti-βactin. (c) The quantity of nectin-1 detected in panel (b) was normalized to the internal
control protein β-actin and plotted. Groups significantly (P<0.05) different from C.
trachomatis-infected cells at 0 h.p.i are indicated by asterisks (*). (d) HeLa cells were
either mock-, HSV-2-, C. trachomatis-, or co-infected. For co-infected HeLa cells, cells
were co-infected with HSV-2 either 24h, 36h or 48h after addition of the chlamydiae.
Cells were collected at 20h post HSV-2 infection and processed for chlamydial EB
titration. Asterisks (*) indicate titres that are significantly different compared with those
from C. trachomatis singly-infected cells (P<0.05). The data shown in this figure are
representative of three independent experiments.
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HSV-induced chlamydial persistence requires nectin-1.
Our published and unpublished data suggest that HSV gD/co-receptor interaction
halts the chlamydial developmental cycle. As a further step in defining if nectin-1 is
involved, we have examined if HSV-induced chlamydial persistence requires nectin-1 by
co-infection using HSV-1 mutants with altered co-receptor specificities. HeLa cells were
either mock-, singly-, or co-infected with C. trachomatis and various wild type (HSV-2
and HSV-1 KOS/FRT-gDwt) or mutant viruses (HSV-1 KOS/FRT-gDG43P, HSV-1
KOS/FRT-gDQ27P, and HSV-1 KOS/FRT-gDA3C/Y38C). HSV-2 (333) co-infection was
used as a positive control for chlamydial persistence induction. The parental stain HSV-1
KOS/FRT-gD expresses wild type gD and enters host cells via HVEM, nectin-1, and 3O-S-HS with high/moderate efficiency and via nectin-2 with very low efficiency. HSV-1
KOS/FRT-gDG43P can only enter using nectin-1. HSV-1 KOS/FRT-gDQ27P uses both
nectin-1 and nectin-2 equally well. Neither G43P nor Q27P use HVEM or 3-O-S-HS,
even when infections are performed at an m.o.i of 200 (Yoon & Spear, 2004). HSV-1
KOS/FRT-gDA3C/Y38C uses HVEM and 3-O-S-HS but not the nectins to enter host cells.
The parental stain and the three mutants also express β-gal activity upon host cell entry
(Yoon & Spear, 2004). Cells were collected at 20h post viral infection and processed for
chlamydial EB titration as described in the Methods. As shown in Fig. 3(a), HSV-2, gDwt
and all three mutants significantly reduced chlamydial EB production. Because we have
found HeLa cells express little or no HVEM and HSV-1 KOS/FRT-gDA3C/Y38C has been
reported to be HVEM/3-O-S-HS specific (Yoon & Spear, 2004), it was unexpected to see
the double mutant represses chlamydial infectivity.
To find out the reason behind this phenomenon, we performed β-gal assays to
check the specific entry phenotypes of HSV-1 KOS/FRT-gDwt, -gDG43P, -gDQ27P, and gDA3C/Y38C using CHO cell lines expressing single co-receptors: CHO-C8, CHO-HVEM,
CHO-nectin-1, and CHO-nectin-2. CHO-C8 cells express cell surface HS but lack any
known HSV co-receptors. As shown in Fig 3(b), as expected, no β-gal activity is
observed in CHO-C8 cells. For gDwt-infected cells, β-gal activity is strongly expressed in
CHO-HVEM and CHO-nectin-1 but is weakly expressed in CHO-nectin-2. These results
were expected because nectin-2 supports HSV-2 entry but is nearly inactive for entry of
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HSV-1. For gDG43P-infected cells, β-gal activity is only present in the CHO-nectin-1 well.
HSV-1 KOS-gDQ27P expresses β-gal activity in both CHO-nectin-1 and CHO-nectin-2
cells, as expected. In gDA3C/Y38C-infected cells, β-gal activity is present in CHO-HVEM
cells. However, we also observed a low, but reproducible, level of β-gal expression in
CHO-nectin-1 cells, which indicates that despite the published reports (Yoon & Spear,
2004), gDA3C/Y38C can attach to and enter nectin-1 expressing CHO cells, albeit at an
efficiency much lower than that observed for HVEM-expressing cells. Given that the
only co-receptor usage that the three mutants share is nectin-1, these data suggest that
virus interaction with this co-receptor is necessary for persistence induction in our system.
We also tested the specific entry phenotypes of HSV-1 KOS/FRT-gDwt, -gDG43P, gDQ27P, and -gDA3C/Y38C on HeLa cells. As shown in Fig. 3(c), no β-gal activity is present
in mock-, C. trachomatis-, HSV-2- or C. trachomatis /HSV-2-infected HeLa cells. As
expected, the wild type (gDwt) and the two mutants (gDG43P and gDQ27P) enter HeLa cells
with high efficiency. However, the double mutant gDA3C/Y38C does not show detectable
entry activity in this assay, which is not surprising since this assay is relatively insensitive
and nectin-1 expression on HeLa cells is much lower than that on CHO-nectin-1 cells, as
shown by the data in Fig. 1(a) (middle panel).
Persistent forms of C. trachomatis have a characteristic electron microscopic
appearance (Beatty et al., 1993; Matsumoto & Manire, 1970). To confirm the results
from Fig. 3(a), we therefore conducted transmission electron microscopy as described in
the Methods. Electron micrographs demonstrated that in C. trachomatis singly-infected
HeLa cells, EBs were present and RBs appeared normal (Fig. 3d). In contrast, in HSV-1
KOS/FRT-gDwt, -gDG43P, -gDQ27P, or -gDA3C/Y38C co-infected HeLa cells, EBs were
absent from chlamydial inclusions and the RB exhibited an enlarged, abnormal
morphology as well as increased membrane blebs, characteristic of persistence (Fig. 3d).
Collectively, these data are again consistent with the supposition that nectin-1 is required
for HSV co-infection-induced chlamydial persistence.
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Figure 4.3 HSV-induced chlamydial persistence requires nectin-1. (a) HeLa cells were
either mock-, singly-, or co-infected with C. trachomatis and various wild type (HSV-2
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and HSV-1 KOS/FRT-gDwt) or mutant viruses (HSV-1 KOS/FRT-gDG43P, HSV-1
KOS/FRT-gDQ27P and HSV-1 KOS/FRT-gDA3C/Y38C). HSV-2 co-infection was used as a
positive control for chlamydial persistence induction. Asterisks (*) indicate titres that are
significantly different compared with those from C. trachomatis singly-infected cells
(P<0.05). (b) CHO cell lines expressing single co-receptors, CHO-C8, CHO-HVEM,
CHO-nectin-1 and CHO-nectin-2, were infected with HSV-1 KOS/FRT-gDwt, -gDG43P, gDQ27P and -gDA3C/Y38C, respectively, for 6 hours. The infected cells were then processed
by β-gal assays as described in the Methods. (c) HeLa cells were either mock-, singly-, or
co-infected with C. trachomatis and HSV-2, HSV-1 KOS/FRT-gDwt, -gDG43P, -gDQ27P or
-gDA3C/Y38C, respectively, for 6 hours. The infected cells were then processed by β-gal
assays as described in the Methods. (d) HeLa cells were either mock-, C. trachomatisinfected or co-infected with C. trachomatis and HSV-2, HSV-1 KOS/FRT-gDwt, -gDG43P,
-gDQ27P or -gDA3C/Y38C, respectively. Cells were harvested for TEM analyses. White
arrows on electron micrographs indicate EBs; Red arrow indicates normal RB; black
arrows indicate abnormal RBs. The data shown are representative of three independent
experiments.

HSV attachment/entry using nectin-1 alone is sufficient to induce chlamydial persistence.
Previous studies indicate that HSV attachment and/or entry into the host cells is
sufficient for inducing chlamydial persistence (Deka et al., 2007), suggesting that viral
attachment/entry may provide the necessary stimulus to trigger a novel host pathway
which restricts chlamydial development (Vanover et al., 2008). To confirm that nectin-1
is, indeed, required for this process, we performed co-infections with C. trachomatis and
HSV-1 KOS in the previously described single co-receptor expressing CHO cell lines.
Cells were first chlamydia infected, and then HSV-1 KOS was added 24 hours later. Cells
were collected at 20h post HSV-1 infection and processed for chlamydial EB titration and
plaque assays. Chlamydial titer analyses demonstrated that though there are differences in
total C. trachomatis production from different CHO cell lines, the characteristic HSV-1induced reduction in chlamydial infectivity is only observed in the positive control coinfected HeLa cells and in co-infected CHO-nectin-1 cells (Fig. 4). As expected,
supernatant plaque assays demonstrate that co-infected CHO-HVEM and CHO-nectin-1
cells produce similar amounts of virus, while CHO-C8 cultures produce essentially none
(data not shown). These data are consistent with our previous observation that HSV-1
enters CHO-HVEM and CHO-nectin-1 cells with high efficiency while showing no
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detectable entry activity in CHO-C8 cells (Fig. 3b). Therefore, these data confirm that
HSV-attachment/entry using nectin-1 co-receptor alone is sufficient to induce chlamydial
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Figure 4.4 HSV attachment/entry using nectin-1 alone is sufficient to induce chlamydial
persistence. HeLa, CHO-C8, CHO-HVEM, CHO-nectin-1 and CHO-nectin-2 were either
C. trachomatis-infected or co-infected with C. trachomatis and HSV-1 KOS. For coinfected cells, Cells were first chlamydia infected, and then HSV-1 KOS was added 24
hours later. Cells were collected at 20h post HSV-1 infection and processed for
chlamydial EB titration. Asterisk (*) indicates titre that is significantly different
compared with that from C. trachomatis singly-infected same cells (P<0.05). The data
shown are representative of three independent experiments.
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Discussion
When exposed to certain adverse environmental factors, developing chlamydiae
deviate from the normal developmental cycle into a viable but non-replicative persistent
state (Hogan et al., 2004) and can remain in this state for weeks or months (Galasso &
Manire, 1961). Persistent chlamydial infections increase the likelihood that an individual
will experience prolonged inflammation of the genital tract and, thus, increasing the
possibilities for development of severe disease sequelae. Several inducers of chlamydial
persistence have been well studied, including interferon-γ (IFN-γ), IFN-α, IFN-β, tumor
necrosis factor-α (TNF-α), and penicillin G exposure, as well as amino acid, iron, and
glucose deprivation (Beatty et al., 1994a; Darville, 2000b; Gerard et al., 2001; Raulston,
1997). Previously, our laboratory has established a tissue culture model of C.
trachomatis/HSV-2 co-infection system. Data from this model indicate that viral coinfection stimulates chlamydiae to become persistent (Deka et al., 2006), as evidenced by
numerous observations: i) fewer or no EBs and enlarged, abnormal RB morphology; ii) a
significant decrease in infectious chlamydial EB production; iii) decreased accumulation
of chlamydial major outer membrane protein (MOMP) and increased accumulation of
chlamydial heat-shock protein HSP-1 (HSP60-1); iv) continued accumulation of
chlamydial genomic DNA and constant expression of chlamydial 16S rRNA transcripts.
Subsequently, Deka et al have demonstrated that viral co-infection-induced
chlamydial persistence is not host cell type-specific because it occurs in both HeLa and
HEC-1B cell lines (Deka et al., 2007). HSV induction of chlamydial persistence is also
not virus-specific due to both HSV-1 and HSV-2 co-infection can interfere with normal
chlamydial development (Deka et al., 2007). Additionally, our laboratory has
demonstrated that co-infection-stimulated chlamydial persistence is not mediated by any
currently characterized persistence inducer or anti-chlamydial pathway (Vanover et al.,
2008), suggesting a novel host pathway may be triggered by viral co-infection to restrict
chlamydial development. Furthermore, co-infection with UV-inactivated, replicationincompetent virus or replication-competent HSV-2 in the presence of cyclohexamide
drives chlamydiae to become persistent, indicating productive viral replication is not
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required for this effect and suggesting that events during HSV attachment/entry are
sufficient to stimulate co-infection-induced persistence (Deka et al., 2007). Finally,
unpublished data from our laboratory demonstrate that exposure of C. trachomatisinfected cells to cross-linked, soluble HSV envelope glycoprotein D:Fc fusion proteins
decreases chlamydial infectivity, indicating that interaction of HSV gD with the host cell
surface is sufficient to stimulate chlamydial persistence (Vanover, 2009a).
HSV gD is the main determinant of cell recognition for viral entry. During the
initial stages of viral invasion, gD binds to one of its co-receptors: nectin-1, nectin-2, 3O-S-HS, and HVEM, followed by fusion of viral envelope and host cell membrane.
Nectin-1 and nectin-2 are important cell adhesion molecules of the immunoglobulin
super-family and are distributed on fibroblasts and epithelial cells. They mainly are
involved in formation and maintenance of adherens and tight junctions (Sakisaka & Takai,
2004). While nectin-1 mediates entry of both HSV-1 and HSV-2, nectin-2 mediates entry
of primarily HSV-2 (Spear, 2004). 3-O-S-HS is widely expressed on human cells and
facilitates HSV-1, but not HSV-2, entry (Spear, 2004). HVEM is a member of the TNF
receptor family. Its natural ligands include LIGHT, B and T lymphocyte attenuator
(BTLA) and lymphotoxin-α (Gonzalez et al., 2005; Sedy et al., 2005). HVEM is present
on lymphoid and epithelial cells and serves as a high-affinity entry co-receptor for both
HSV-1 and HSV-2 (Spear, 2004). However, Montgomery et al. have shown that HVEM
is probably not the primary receptor for HSV entry into HeLa cells, even HVEM cDNA
was originally cloned from a HeLa cell library, because anti-HVEM serum only had
marginal effects on the entry of HSV-1 into HeLa cells (Montgomery et al., 1996). On
the other hand, unpublished data by Vanover et al. from our laboratory have shown that
non-crosslinked soluble HSV-2 gD:Fc fusion proteins interaction with HeLa cells did not
stimulate chlamydial persistence. However, when chlamydiae-infected HeLa cells
exposed to immunoglobulin cross-linked gD:Fc fusion proteins, the developing
chlamydiae became persistent (Vanover, 2009a). Interestingly, the dimerizing of nectins
is required for nectin trans-interaction induced downstream cell signaling cascades (Ogita
& Takai, 2006b). Finally, our studies have shown that both HSV-1 and HSV-2 can drive
developing chlamydiae to enter persistence state (Deka et al., 2007). Thus, collectively,
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these observations suggest that, of the four known co-receptors, nectin-1 is the most
potential candidate for stimulating HSV co-infection-induced chlamydial persistence in
this system.
In the present study, the goal was to test the hypothesis that nectin-1 is required
for HSV co-infection-induced chlamydial persistence. We first examined which HSV coreceptors were expressed in HeLa and HEC-1B cells based on the fact that HSV coinfection-induced persistence occurs in both HeLa and HEC-1B cells (Deka et al., 2007).
Notably, both Western blot and RT-PCR analyses demonstrate that HeLa and HEC-1B
cells express nectin-1 and nectin-2, but not HVEM. These observations are consistent
with the supposition that nectin-1 is the most likely candidate for stimulation of coinfection-induced persistence. Secondly, co-infection studies in C. muridarum revealed
that a significant decrease in chlamydial infectivity occurs in co-infected cells when
HSV-2 is added at 6h and 12h but not at 24h post-chlamydial infection. The effect caused
by HSV-2 on C. muridarum infectivity is greater at 6h than at 12h. Additional studies
demonstrate that there is a nearly 68% reduction in host cellular nectin-1 by 24 hours
post-C. muridarum infection. These data suggest that HSV co-infection does not interfere
with chlamydial development in the absence of nectin-1, which supports the hypothesis
that nectin-1 interaction with HSV is probably required for stimulating a novel host
pathway to induce chlamydial persistence. Thirdly, using HSV-1 mutants with altered coreceptor specificities, we examined whether HSV co-infection-induced chlamydial
persistence requires nectin-1 by chlamydial titration assay and TEM. Surprisingly, we
found that co-infection in HeLa cells with the parental strain HSV-1 KOS/FRT-gDwt or
the three HSV-1 mutants HSV-1 KOS/FRT -gDG43P, -gDQ27P, and -gDA3C/Y38C drove the
chlamydiae to become persistent. These results were unexpected because HeLa cells do
not express HVEM (Fig. 1a) and -gDA3C/Y38C is only HVEM/3-O-S-HS specific (Yoon &
Spear, 2004). However, we observed later by β-gal assays that despite the reported results
that gDA3C/Y38C enters cells via HVEM and 3-O-S-HS (Yoon & Spear, 2004), gDA3C/Y38C
has lower ability to attach to and enter nectin-1-expressing CHO cells. Therefore, the
only co-receptor usage that the parental strain and the three mutants share is nectin-1.
Because β-gal assay is relatively insensitive and nectin-1 expression on HeLa cells is
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much lower than that on CHO-nectin-1 cells (Fig. 1a), it is not surprising to see no
detectable β-gal activity of gDA3C/Y38C in HeLa cells. Finally, we determined whether
HSV attachment/entry using nectin-1 co-receptor alone is sufficient to stimulate
chlamyidal persistence using co-receptor-deficient CHO cell lines. The results
demonstrated that HSV-1-induced reduction in chlamydial infectivity is only observed in
positive control HeLa co-infection and in CHO-nectin-1 cells, but not in CHO-C8, CHOHVEM, and CHO-nectin-2 cells. Although Western blotting and RT-PCR analyses
demonstrated that HeLa cells and HEC-1B cells do not express HVEM, it is possible that
the expression of HVEM is below our detection level. However, the fact that CHOnectin-1 cells support persistence during co-infection while CHO-HVEM cells do not
provides very strong evidence that HSV interaction with nectin-1 triggers viral coinfection-induced persistence. It is especially important to point out that HSV-1 enters
and produces progeny virions in both CHO-nectin-1 and CHO-HVEM cells, but
chlamydial infectivity is decreased only when nectin-1 is present. These data suggest that
co-infection induced persistence specifically results from HSV gD/nectin-1 interaction
with nectin-1, rather than from events that occur during or subsequent to virion entry.
Overall, these observations confirmed that nectin-1 is indeed required for HSV coinfection-induced chlamydial persistence.
As mentioned before, HSV co-infection-induced chlamydial persistence is not
mediated by any known persistence inducer or anti-chlamydial pathway (Vanover et al.,
2008), suggesting a novel host signaling pathway activated by interaction of HSV gD
with nectin-1 could have a negative effect on chlamydial development. Studies have
shown that the trans-interactions of nectins induce activation of cellular signaling
molecule Cdc42 small G proteins through c-Src. The activation of Cdc42 and c-Src
furthermore cause the activation of Rac small G proteins. Activated Cdc42 and Rac
selectively induce activation of c-Jun N-terminal kinase, but not p38 MAP kinase or
extracellular signal-regulated kinase (ERK) (Takai et al., 2003). Eventually, activated
Cdc42 and Rac are involved in regulation of cell-cell adhesion, gene expression and cell
polarization (Takai et al., 2003). Interestingly, temporarily activated Cdc42 and Rac1
have been observed at 15 and 30 min after HSV-1 infection of MDCK canine kidney
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cells (Hoppe et al., 2006). It is very intriguing to envision that HSV/nectin-1 interactionactivated chlamydial persistence response is transmitted through the Cdc42/Rac1
signaling pathway. However, active GTPase pull-down assays indicate that Cdc42 is not
activated in co-infected HeLa cells (see supplementary data, Fig. S4.2), suggesting this
anti-chlamydial response is likely mediated through another, as yet uncharacterized,
nectin-1-activated host signaling pathway. Identification of this uncovered nectin-1activated cellular signal transduction pathway will be conducted in future in that
dissection of this pathway will increase our understanding of the host immune response
to chlamydial infection and provide new and valuable information of chlamydia/host cell
interaction.
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Supplementary Figure 4.1 (a) and (b) HeLa and HEC-1B cells express nectin-1 and
nectin-2. Total RNA from HeLa, HEC-1B and the appropriate CHO control cell lines was
isolated and subjected to RT-PCR using specific primers for nectin-1α, -1β, -1γ and
nectin-2. In each experiment, a four log dilution series of synthetic control DNA was
used to generate standard curves for amplification. Experimental samples were only
quantified if they fell within the linear range of the PCR. The position of DNA size
markers are shown to the left of each gel image in base pairs (bp).
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Supplementary Figure 4.2 Endogenous Cdc42 activities upon HSV-1 infection. HeLa
cells at low density were infected with HSV-1. The levels of GTP-bound Cdc42 were
determined in uninfected cells (mock) and in cells at 15, 30, 60, 120 min post-infection.
Pull-down experiments were performed according to the manufacturer’s instructions
(#89857, Active Cdc42 Pull-Down and Detection Kit, Thermo Scientific). Equal amounts
of samples were resolved on SDS-PAGE gels and subjected to Western blotting using
mouse anti-Cdc42 antibodies. In vitro GTPγS and GDP control treatments were
performed to ensure the pull-down procedures were working properly.
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Supplementary Table S4.1. RT-PCR primers and positive control oligonucleotides.
Name

Forward primer

Reverse primer

Nectin-2

TCGGAGCACAGCCCACTCAA

TTGTGGCTCCAGGGTGCA

HVEM

TGTGTGAACCCTGCCCTCCA

GCGTTCTCTGTCCTGGAGCA

Nectin-2 positive

CCTCGGAGCACAGCCCACTCAAGACCCCCTACTTTGATGCTGGCGC
CTCATGCACTGAGCAGGAAATGCCTCGATACCATGAGCTGCCCACC
TTGGAAGAACGGTCAGGACCCTTGCACCCTGGAGCCACAAGCCTGG
GG

control
oligonucleotide
HVEM positive
control
oligonucleotide

CACAGTGTGTGAACCCTGCCCTCCAGGCACCTACATTGCCCACCTC
AATGGCCTAAGCAAGTGTCTGCAGTGCCAAATGTGTGACCCAGCCA
TGGGCCTGCGCGCGAGCCGGAACTGCTCCAGGACAGAGAACGCCGT
GT
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CHAPTER 5
CONCLUSIONS
Over the years, extensive research efforts have been put into uncovering the
pathogenic mechanisms by which C. trachomatis causes disease. Numerous
investigations have revealed that C. trachomatis has evolved a variety of strategies to be
able to productively replicate and persistently survive within the eukaryotic host cell. For
example, upon infection, C. trachomatis prevents infected cells from undergoing
apoptosis, which allows the chlamydiae to maintain long-term infection within host cells.
C. trachomatis can also alter host cell-cell contacts and signal transduction pathways,
facilitating chlamydial growth. Finally, C. trachomatis also modifies the host cell
cytoskeleton, benefiting chlamydial intravacuolar replication.
In our study, we first showed that nectin-1, an important component of host cell
adhesion junctions, is significantly decreased in C. trachomatis-infected genital epithelial
cells (Sun et al., 2008). We further demonstrated that CPAF, a chlamydia-secreted
protease, is responsible for nectin-1 degradation (Sun, 2009). Recently, several
investigators have reported data that suggest that CPAF has important roles in chlamydial
replication, growth, and dissemination. Zhong et al. reported that CPAF cleaves RFX5,
USF-1, pro-apoptotic BH-3 only proteins and keratin-8. RFX5 and USF-1 are
transcription factors, which are required for MHC class I and II antigen expression
(Zhong et al., 1999; Zhong et al., 2000). Cleaving RFX5 and USF-1 as well as subquent
suppressing MHC class I and II antigen expression may help infected cells escape
immune detection. Therefore, the chlamydiae would have sufficient time to complete
their replication in infected hosts. Pro-apoptotic BH-3 only proteins are required for
apoptosis in response to cytotoxic stimuli or exogenous stress, and they function by
neutralizing their pro-survival counterparts or activating pro-apoptotic Bcl-2 family
members Bax and Bak (Pirbhai et al., 2006). Down-regulation of BH-3 only proteins
contributes to chlamydial anti-apoptotic activity which may help chlamydiae evade CTLmediated host cell apoptosis induction and, thus, benefit chlamyidal long-term survival
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within infected host cells (Pirbhai et al., 2006). Keratin-8 is a component of intermediate
filaments and is also a major plasminogen receptor in select epithelial and carcinoma
cells (Dong et al., 2004c). Cleavage of keratin-8 would increase the solubility of the host
cell cytoskeleton, thus facilitating the expansion of chlamydia-laden inclusion, which is
essential for chlamydial intracellular replication. Kawana et al. also found that CPAF can
effectively degrade CD1d glycoprotein, an MHC-like protein that presents lipid antigen
to natural killer T cells (Kawana et al., 2007). Degradation of CD1d protein may prevent
recognition or elimination of chlamydiae from the host innate immune system (Kawana
et al., 2007). Balsara et al. demonstrated that CPAF activity induces proteolysis of
mitotic cyclin B1, a protein involved in cell cycle, resulting in a slowed progression of
infected cells through the later stages of the cell cycle (Balsara et al., 2006).
Unfortunately, the lack of a genetic system in chlamydiae has made it difficult to directly
determine whether CPAF function is necessary for chlamydial development or disease.
However, several indirect observations suggest that CPAF is, indeed, vitally important
for development and/or establishment of infection. First, all chlamydial genomes yet
sequenced contain a CPAF homologue (Read et al., 2000; Read et al., 2003; Stephens et
al., 1998). It seems unlikely that the gene would be evolutionarily maintained if it were
not required for progression of the developmental cycle or successful infection by the
organism. Second, immunization of naive mice with purified CPAF protein induces an
immune response that protects against subsequent vaginal challenge with C. muridarum
(Li et al., 2007; Li et al., 2008), indirectly indicating that CPAF is likely to be important
for maintenance of infection in vivo. Given these data, CPAF likely has critical roles in
both protecting infected cells from host immune detection and facilitating chlamydial
intracellular growth and survival. Thus, it appears that chlamydiae have evolved a single
molecule (CPAF) for multiple purposes.
What are the possible biological consequences of nectin-1 degradation? As
mentioned before, nectin-1 is an adhesion molecule that is critically important for the
formation and maintenance of AJs and TJs. As a result, we would predict that
degradation of nectin-1 would inevitably affect the integrity of host cell-cell junctions.
This notion is supported by recent data showing that cervical epithelial cells separate
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from each other as a consequence of C. trachomatis infection (Prozialeck et al., 2002).
Numerous studies have shown that some important human pathogens, such as
Helicobacter pylori, Shigella flexneri and Salmonella typhimurium, down-regulate
essential components of adhesion and tight junctions including E-cadherin, claudin-1, and
ZO-1. This down-regulation leads to decreased transepithelial electrical resistance and
increased paracellular permeability, which facilitates cell-to-cell spreading of these
pathogens (Jepson et al., 1995; Sakaguchi et al., 2002; Sears, 2000; Terres et al., 1998).
These findings suggest that disruption of adhesion and tight junctions to compromise
cell-cell barriers may be an important strategy exploited by intracellular pathogens to
ensure their dissemination. Although C. trachomatis serovar E is not an invasive
pathogen, it may diminish nectin-1 expression and subsequently disrupt cell-cell
adhesions, aiding lateral cell-to-cell spread. Alternatively, nectin-1 down-regulation
might facilitate host structural rearrangements required for inclusion enlargement or EB
release at the end of the developmental cycle. This prediction is supported by the
observation that nectin-1 accumulation starts to decrease at 36 hpi, which is middevelopmental cycle for C. trachomatis serovar E (Sun et al., 2008).
Another intriguing possibility is that CPAF-mediated down-regulation of nectin-1
might facilitate long distance C. trachomatis dissemination within the host genital tract
(Fig. S2.3). Weakening of contacts by CPAF between an infected host genital epithelial
cell and adjacent, uninfected cells could allow release of the intact, infected cell into
genital tract lumen. The infected cell would then drift away via fluid dynamics or tissue
movement from the original infection site to a new tissue site, aiding establishment of
ascending genital tract infection. Notably, release of intact, chlamydiae-infected host
cells from polarized monolayers in culture (Wyrick et al., 1989) as well as from infected
epithelium in vivo has been observed (Doughri et al., 1972; Rank et al., 2008; Soloff et
al., 1985). Soloff et al. (Soloff et al., 1985) and Doughri et al. (Doughri et al., 1972)
observed that PMNs are in direct contact with epithelial cells in guinea-pig cervical cells
infected with C. caviae and bovine intestinal epithelial cells infected with C. psittaci,
respectively. Recently, Rank et al. (Rank et al., 2008) have observed a similar
phenomenon in in vivo using a guinea-pig conjunctival model of C. caviae infection.
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They also presented ultrastructural evidence that, in contrast to lysis of infected cells, the
majority of infected cells are pushed off the epithelium. Most of the detached, infected
cells appear to be healthy with intact microvilli, nuclei, and mitochondria. Rank et al.
further proposed that PMNs responding to chlamydial infection participated in the
detachment of chlamydia-infected cells from the mucosal surface, resulting in the release
of intact, infected cells. As PMN infiltration intensifies, they also observed breaches in
the epithelial monolayer, resulted from weakened and disrupted epithelial tight junctions,
desmosomes and junctional complexes. These data are consistent with our observation
that nectin-1 is degraded by CPAF in C. trachomatis-infected genital epithelial cells.
Thus, it appears reasonable to hypothesize that the PMNs literally push intact, infected
cells out of the mucosal epithelial layer. Given our data, we would assert that the
chlamydia-mediated down-regulation of nectin-1 facilitates this process by loosening the
junctions between adjacent host epithelial cells (Fig. 5.1). If nectin-1 degradation does
indeed facilitate release of intact, infected cells from the genial mucosa, the question
remains - how might this process benefit the chlamydiae? We would propose that release
of infected cells provides at least two beneficial functions. First, the detached infected
cells provide a protected niche for chlamydial EBs from neutralization by secretory IgA,
cationic anti-microbial peptides and other anti-bacterial compounds in surrounding
environment. Second, the inflammatory reaction is very intense at the local site of
original infection because of increased local production of IFN-gamma and other antichlamydial cytokines; it is therefore likely that few susceptible cells would be available.
The dislodging of infected cells may allow the chlamydial EBs to be delivered to new,
uninfected tissue sites in the genital tract. Once the infected cells ruptured, the local
concentration of infectious EB would be very high, increasing the possibility that
mucosal epithelia would be successfully infected. In contrast, EBs liberated from host
cells still within the genital epithelial layer would be both quickly diluted and
immediately subject to neutralization by anti-bacterial compounds. An in vitro time-lapse
cinematographic study by Neeper et al showed the dramatic bursting of an infected cell to
release EBs into the surrounding milieu (Neeper et al., 1990). Thus, based on the
available information, we envision that the detached, inclusion-containing epithelial cell
would act like a chlamydial “cluster bomb”, allowing delivery of a concentrated
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inoculum over a relatively long distance and increasing the possibility of a “hit” if the
host cell ruptured near the genital epithelial cell layer. More importantly, this mechanism
may also help to explain how the chlamydiae ascend the genital tract from the initial site
of infection in the cervix to the fallopian tubes in the female patients.
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Figure 5.1 Potential roles of nectin-1 down-regulation and PMNs in C. trachomatis
dissemination within the host genital tract. Red dots represent EBs; grey circles represent
RBs.

Another interesting possibility is that nectin-1 may facilitate chlamydial entry and
that down-regulation of nectin-1 may be used by the chlamydiae to reduce the possibility
of subsequent infection of the same cell by other chlamydiae. This would be analogous to
viral interference, a phenomenon defined as protection of host cells against subsequent or
re-infection by similar viruses, conferred as a result of prior infection with a different
virus. One common mechanism of viral interference occurs when a virus down-regulates
its receptor after infecting a host cell. The possibility that chlamydiae use nectin-1 downregulation to reduce subsequent infection of the same cell with other chlamydiae is
supported by our and others’ observations. In our study, more infectious chlamydiae are
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produced from C. trachomatis-infected CHO-necin-1 cells than from the other CHO cell
lines, even in the absence of HSV co-infection (Fig. 4.4). One possible explanation for
this observation is that chalmydiae enter cells that have nectin-1 (like HeLa and CHOnectin-1) more efficiently than they enter cells that don't have nectin-1. The chlamydiae
might then down-regulate nectin-1 to reduce the efficiency with which other chlamydiae
enter. Moulder et al. have found that mouse fibroblasts (L cells) infected with C. psittaci
(strain 6BC) are resistant to superinfection with the same strain (Moulder et al., 1980).
Later, they observed that exogenous 14C-labeled C. psittaci does not attach to C. psittaciinfected L cells at measurable rates. However, when exogeneous C. psittaci chlamydiae
are centrifuged onto host cell monolayers or added to monolayers pretreated with the
polycation diethylaminoethyl (DEAE)-dextran, they enter C. psittaci-infected L cells and
multiply normally (Moulder et al., 1981). Polyacrylamide gel electrophoresis of L cell
proteins surface labeled with 125I by lactoperosidase-catalyzed iodination revealed
widespread differences in surface labeling between wild-type and C. psittaci-infected L
cells. Particularly, the most prominent change is the generalized reduction in intensity of
labeling of proteins migrating in the molecular weight range from 60kDa to 100kDa.
These observations suggest that resistance to superinfection is caused by chlamydiaindcued changes in the structure or cell surface expression of the putative host cell C.
psittaci receptor(s) (Moulder et al., 1982). As we mentioned in Chapter 2, the molecular
weight of nectin-1 is about 75kDa, which falls in the range of 60-100kDa. Also, nectin-1
accumulation starts to significantly decrease in C. trachomatis-infected HeLa cells at 36
hpi, which is mid-developmental cycle for C. trachomatis serovar E. Although Ridderhof
et al have shown that prior infection does not influence superinfection with another
serovar of C. trachomatis during the first 24h following the initial infection (Ridderhof &
Barnes, 1989), they did not investigate times after 24 hpi. It is, therefore, possible that
superinfecting chlamydae added after 36 hpi are less able to enter the same cell when
nectin-1 is significantly degraded. This possibility assumes that nectin-1 is actually
required for efficient chlamydial entry. Because there are several other possible
explanations for our observation, defining any role of nectin-1 in chlamydial entry will
await future experiments.
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In Chapter 4, we focused specifically on identifying the co-receptor that HSV
exploits to drive C. trachomatis to enter a persistent state. Previous data from our
laboratory and observations from other investigators strongly suggest that nectin-1 has
the most potential for triggering HSV co-infection-induced chlamydial persistence. First,
both HVEM and nectin-1 serve equally well as co-receptors for HSV-1 and HSV-2 entry
(Spear, 2004). In contrast, nectin-2 primarily mediates entry of HSV-2 and 3-O-S-HS
only facilitates HSV-1 entry (Spear, 2004). Therefore, our previously published
observation that both HSV-1 and HSV-2 are capable of inducing chlamydial persistence
(Deka et al., 2007) greatly diminish the possibility that either nectin-2 or 3-O-S-HS
deliver the persistence signal. Thus, HVEM and nectin-1 are the strongest candidates for
triggering persistence. Second, although HVEM cDNA was originally isolated from a
HeLa cell library, Montgomery et al have shown that HVEM is probably not the primary
receptor for HSV entry into HeLa cells in that anti-HVEM serum only had marginal
effects on the entry of HSV-1 into HeLa cells (Montgomery et al., 1996). Last,
unpublished data by Vanover et al. from our laboratory have shown that non-crosslinked
HSV-2 gD:Fc fusion proteins interaction with HeLa cells did not stimulate chlamydial
persistence. However, when chlamydiae-infected HeLa cells were exposed to
immunoglobulin cross-linked gD:Fc fusion proteins, the developing chlamydiae became
persistent (Vanover, 2009b). It has been reported that the dimerizing of nectins is
required for nectin trans-interaction induced downstream cell signaling cascades (Ogita
& Takai, 2006a). Perhaps cross-linking gD:Fc fusion proteins increases receptor
aggregation and thus, increases the efficiency of downstream cell signaling. Collectively,
these data suggest that, of the 4 known co-receptors, nectin-1 is the most likely candidate
for stimulating persistence in this system.
The goal of the experiments presented in Chapter 4 was to test the hypothesis that
nectin-1 is required for HSV co-infection-induced chlamydial persistence. First, because
previous data from our laboratory indicated that HSV co-infection triggers chlamydial
persistence in both HeLa and HEC-1B cells (Deka et al., 2007), we ascertained which
HSV co-receptors were expressed in these two cell types. Importantly, both Western
blotting and RT-PCR analyses demonstrated that HeLa and HEC-1B cells express nectin-
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1 and nectin-2, but not HVEM (Fig. 4.1a,b). Second, co-infection studies in C.
muridarum revealed that a significant decrease in chlamydial infectivity occurs in coinfected cells when HSV-2 is added at 6h and 12h, but not at 24h post-chlamydial
infection. Additional studies demonstrated that there is a nearly 68% reduction in host
cellular nectin-1 by 24 hours post-C. muridarum infection (Fig. 4.2b,c). These data
suggest that HSV co-infection does not interfere with chlamydial development in the
absence of nectin-1. Third, co-infection studies in HeLa cells with C. trachomatis and coreceptor-specific HSV-1 mutants indicated that parental strain HSV-1 KOS/FRT-gDwt
and the three HSV-1 mutants HSV-1 KOS/FRT -gDG43P, -gDQ27P, and -gDA3C/Y38C all
drive developing chlamydiae to become persistent (Fig. 4.3a,d). β-gal assays further
demonstrated that the only co-receptor usage that the parental strain and the three mutants
share is nectin-1 (Fig. 4.3b,c). Last, we determined that HSV attachment/entry using the
nectin-1 co-receptor alone is sufficient to stimulate C. trachomatis to enter persistence
using co-receptor-deficient CHO cell lines (Fig. 4.4). The results demonstrated that HSV1-induced reduction in infectious EB production is observed in HeLa cell controls and
CHO-nectin-1 cells, but not in CHO-C8, CHO-HVEM and CHO-nectin-2 cells. Although
our results demonstrated that HeLa cells and HEC-1B cells do not express HVEM, it is
possible that the expression of HVEM is below our detection level. However, the fact that
CHO-nectin-1 cells support persistence during co-infection while CHO-HVEM cells do
not provides very strong evidence that HSV interaction with nectin-1 triggers viral coinfection-induced persistence. It is especially important to point out that HSV-1 enters
and produces progeny virions in both CHO-nectin-1 and CHO-HVEM cells, but
chlamydial infectivity is decreased only when nectin-1 is present. These data suggest that
co-infection induced persistence specifically results from HSV gD/nectin-1 interaction
with nectin-1, rather than from events that occur during or subsequent to virion entry.
Overall, these observations confirmed that nectin-1 is indeed required for HSV coinfection-induced chlamydial persistence.
Studies by Vanover et al. demonstrated that HSV-2 co-infection-induced
chlamydial persistence is not mediated by any currently known persistence inducer or
anti-chlamydial pathway (Vanover et al., 2008), suggesting a novel anti-chlamydial
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pathway might be activated during HSV co-infection. As mentioned before, co-infection
of HeLa cells with either replication incompetent HSV-2uv or with replication-competent
HSV-2 in the presence of cyclohexamide continues to drive C. trachomatis to enter a
persistent state, suggesting that productive HSV replication is not required and that
events during HSV attachment and/or entry are sufficient to stimulate chlamydial
persistence (Deka et al., 2007). Further, co-incubation of either fixed, HSV-2-infected
inducer cells or recombinant HSV gD protein with viable, C. trachomatis-infected
responder cells suppresses infectious EB production and stimulates the formation of
abnormal RBs. These data suggest the events that occur during viral attachment, instead
of viral entry, are sufficient to provide stimulus to alter C. trachomatis development
(Vanover, 2009b). HSV attachment to host cell occurs in several consecutive steps and
involves viral glycoproteins binding to their cognate host cell receptors/co-receptors
(Spear, 2004). It is known that HSV/host cell surface interactions activate several host
cellular signaling cascades. Therefore, it is possible that HSV binding to host cell
receptors/co-receptors could stimulate chlamydial persistence by activating cellular
signaling pathways that have negative effects on chlamydial development.
A number of studies have demonstrated that HSV triggers anti-viral pathways via
Toll-like receptors (TLRs), important critical mediators in generating innate immune
responses against viral pathogens (Aravalli et al., 2005; Kurt-Jones et al., 2005; Pyles et
al., 2002). This information raises the possibility that stimulation of anti-viral signals
during co-infection could have anti-chlamydial effects. HSV gB is reported to be the
major glycoprotein responsible for inducing TLR-linked anti-viral transduction cascades
in host cells (Aravalli et al., 2007; Kurt-Jones et al., 2005). However, unpublished data
from our laboratory indicate that specific antibody neutralization of HSV gB, gC, or gH
is not able to restore chlamydial infectivity during co-infection. Further studies by
Vanover et al. demonstrate that co-incubation of recombinant HSV gD protein with C.
trachomatis-infected HeLa cells induces persistence, demonstrating that HSV gD
interaction with the host cell surface is sufficient to alter the chlamydial developmental
cycle (Vanover, 2009b). Notably, IFN-β is one of the first genes activated by HSVinduced TLR signaling (Schneider et al., 2004). However, semiquantitative RT-PCR
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studies demonstrate that IFN-β mRNA is not expressed during co-infection (Vanover et
al., 2008). Finally, the data presented in Chapter 4 demonstrate that HSV co-infection
inhibits the chlamydial developmental cycle in nectin-1-expressing but not in control
CHO-C8 cells. Since the CHO control cells and CHO-nectin-1 cells are identical, except
for the presence or absence of nectin-1, it seems unlikely that the observed effect is TLR
mediated. Therefore, collectively, these observations indicate that HSV interaction with
TLRs is not the mechanism underlying the phenomenon of co-infection-induced
persistence.
Currently, our data indicate that nectin-1, a co-receptor that interacts with the
HSV envelope gD, is required for triggering chlamydial persistence during co-infection.
As a member of Immunoglobulin superfamily and an important component of AJs, when
stimulated, nectin-1 activates the cell signaling molecule Cdc42 through c-Src. The
activation of Cdc42 and c-Src further cause the activation of the small G protein, Rac.
Activated Cdc42 and Rac then selectively induce activation of c-Jun N-terminal kinase
(JNK), but not p38 MAP kinase or extracellular signal-regulated kinase (ERK) (Takai &
Nakanishi, 2003). The JNK pathway is involved in important cellular events such as
apoptosis and cell growth (Sakisaka & Takai, 2004). Eventually, activated Cdc42 and
Rac are involved in regulation of cell-cell adhesion, gene expression and cell polarization
(Takai & Nakanishi, 2003). Interestingly, temporarily activated Cdc42 and Rac1 have
been observed at 15 and 30 min after HSV-1 infection of MDCK canine kidney cells
(Hoppe et al., 2006). It is very tempting to envision that the HSV/nectin-1 interactionactivated chlamydial persistence response is transmitted through the Cdc42/Rac1
signaling pathway. However, active GTPase pull-down assays indicate that Cdc42 is not
activated in co-infected HeLa cells (Fig. S4.2), suggesting this anti-chlamydial response
is likely mediated through another, as yet uncharacterized, nectin-1-activated host
signaling pathway. In addition, nectin-1 has at least one natural endogenous ligand:
nectin-3. It is, therefore, possible that interactions between nectin-1 and nectin-3 could
also trigger anti-chlamydial pathways causing persistence in the absence of co-infection.
Thus, investigating the interactions between nectin-1 and nectin-3 might provide a clue
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regarding which signaling pathway is stimulated and if it activates an anti-chlamydial
response.
Several studies demonstrate that HIV or human cytomegalovirus (HCMV)
binding of viral glycoproteins to the host cell surface is sufficient to induce a Ca2+ influx
into the cells (Alfano et al., 1999; Keay et al., 1995; Keay & Baldwin, 1996; Liu et al.,
2000). Cheshenko et al. recently reported that the calcium-signaling pathway is also
rapidly activated, with an increased [Ca2+] in the cytosol, after exposure to HSV
(Cheshenko et al., 2003). They further proposed that a signal is transduced after
interactions between heparan sulfate proteoglycans and gC or gB, as well as engagement
of HSV co-receptors by gD. The transduced signal in turn activates the inositol-1,4,5triphosphate (IP3) pathway, leading to a rapid increase in [Ca2+]. The increased [Ca2+]
may further promote phosphorylation pathways, facilitating viral penetration and/or the
transport of incoming viral capsids to the nucleus (Cheshenko et al., 2003). Calcium
signaling has been shown to be important for C. trachomatis intracellular survival. For
example, type III secretion systems (T3SSs) are unique mechanisms that Gram-negative
bacteria use to modulate the host cell environment by delivering bacterial effector
proteins into the host cell. Studies show that low calcium enhances the induction of
T3SSs in C. trachomatis (Jamison & Hackstadt, 2008). Shainkin-kestenbaum et al. also
reported that the growth of C. trachomatis is inhibited by addition of calcium antagonist
verapamil (Shainkin-Kestenbaum et al., 1989). It is possible that fluctuation of host
cellular calcium levels stimulated by HSV gD/nectin-1 interaction may play a role in C.
trachomatis intracellular life. Therefore, development of chlamydial persistence by a
mechanism that acts via triggering calcium-signaling pathways during co-infection could
be a possibility.
Other possible signaling pathways involved in induction of persistence in C.
trachomatis/HSV co-infected cells include the NF-kB and the JAK/STAT signaling
pathways. Both HSV-1 gD and UV-inactivated virions are able to stimulate NF-kB
activity from 1-3 hpi (Amici et al., 2006; Teresa Sciortino et al., 2007). HSV infection
can cause down-regulation of the JAK/STAT signaling pathway by inducing host cells to
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express SOCS3 (Yokota et al., 2005). However, further experimental examination is
necessary to determine whether these signaling pathways are required for co-infectioninduced persistence. Of course, it is always possible that some unknown signaling
pathways are activated by attachment of HSV that in turn cause the induction of
chlamydial persistence. It is also possible that several activated host signaling pathways
may work together to negatively affect developing chlamydiae. In the future, we plan to
screen HSV-infected as well as gD-co-incubated HeLa cells using commercially
available phospho-protein-specific antibody microarrays. Once we have a more global
view of the host signalling pathways activated by HSV and gD-host cell interaction,
specific pharmacologic, dominant-negative and RNAi inhibitors of those pathways will
be used to determine which might be involved in this response. Thus, we hope ultimately
to determine which signaling pathway is responsible for viral co-infection-induced
chlamydial persistence.
As mentioned before, HSV and C. trachomatis are two of the most common STD
agents in the United States and co-infection with HSV and C. trachomatis has been
observed clinically. Published data from our laboratory demonstrate that HSV-2 superinfection of C. trachomatis serovar E-infected human genital epithelial cells profoundly
alters the chlamydial developmental cycle, driving developing chlamydiae to enter
persistence. Induction of chlamydial persistence by HSV-2 co-infection has significant
implications for pathogenesis. Persistent chlamydiae are refractory to killing by antichlamydial drugs, enhancing the likelihood that an individual will experience prolonged
inflammation of the genital tract and thus increasing the possibility for development of
severe disease sequelae such as pelvic inflammatory disease and ectopic pregnancy.
Therefore, it is possible that the severity of the inflammatory response caused by HSV2/C. trachomatis co-infection might be even higher than that in an individual infected
with C. trachomatis alone. Most of the morbidity associated with chlamydial infections is
due to complications arising from the infection, which are thought to be due, at least in
part, to release of inflammatory mediators from infected cells. Thus, any stimulus that
increases release of these compounds might enhance disease pathology. Numerous
membrane blebs have been observed in HSV/C. trachomatis co-infected cells. The
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presence of membrane blebs has been associated with release of chlamydial LPS from
persistently infected cells (Karimi et al., 1989; Wyrick et al., 1999). Although chlamydial
LPS is less potent than that of other Gram-negative bacteria, it still has the capacity to
enhance the host inflammatory response (Ingalls et al., 1995). HSV-2 co-infection also
increases the accumulation of chlamydial immuno-stimulatory antigen cHSP60 (Deka et
al., 2006). Increased cHSP60 production would be predicted to result in an increase in
inflammation that in turn will lead to an increase in tissue damage. An increase in tissue
damage implies an increase in the complications resulting from chlamydial infection.
Given that productive HSV replication generally kills the host cell, co-infection
induced chlamydial persistence may seem to have little in vivo relevance. However, data
from our laboratory demonstrate that productive viral replication is not required for the
induction of chlamydial persistence (Deka et al., 2007). It is estimated that about 50-200
defective virions are released for every replication competent virion produced (Roizman,
2001b). Thus, there may be numerous non-viable viral particles able to attach and enter in
vivo. Because these defective virus particles are incapable of productive replication, lysis
of the host cell does not occur. Because only HSV gD is required for triggering
chlamydial persistence (Vanover, 2009b), attachment of defective virions or soluble gD
protein to C. trachomatis-infected cells could stimulate persistence without killing the
host cells. This implies that the persistent chlamydiae could survive within co-infected
host cells and contribute to pathogenesis in vivo. As a result, persistence induced by
defective virions is likely of higher in vivo relevance in co-infected individuals than that
induced by replication-competent virions. More importantly, these exposure conditions
are more likely to accurately mimic stimulation of the anti-chlamydial pathway by
existing endogenous host ligands than does co-infection with replication-competent HSV.
If nectin-1 binding to its endogenous ligands, like nectin-3, can indeed induce chlamydial
persistence, this response is likely to have tremendous in vivo significance because it
would be expected to occur in all chlamydia-infected individuals, not just those coinfected with HSV.
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The possibility that nectin-1 interaction with endogenous host nectin-1 ligands
also opens up a fascinating alternative explanation for the nectin-1 down-regulation
observed in both C. trachomatis- and C. muridarum-infected cultures. Previously, we
hypothesized that nectin-1 diminution might facilitate chlamydial dissemination in the
genital tract or serve as a mechanism by which the chlamydiae interfere with re-infection
of the host cell. Although both alternatives are still quite possible, another hypothesis
suggested by the data in Chapter 4 is that the chlamydiae degrade nectin-1 to evade
nectin-1-mediated inhibition of the developmental cycle. This opens up the even more
exciting possibility that nectin-1 and other endogenous host factors might tightly regulate
chlamydial development in the host cell. Although this is an almost entirely unexplored
facet of chlamydia-host interaction, it is not without precedent in the STD field. The
replication cycle of Human Papilloma Virus (HPV) is closely regulated by interactions
between viral oncoproteins and host cell factors. During HPV infection, viral genomes
are coordinately replicated along with the cellular DNA. Upon cell division, viral DNA is
partitioned to two daughter cells. One daughter cell will remain undifferentitated, serving
as a reservoir for continued infection. The other daughter cell will detach from the basal
layer and differentiate in the suprabasal epithelium (Longworth & Laimins, 2004). In
normal uninfected epithelia, cells exit the cell cycle once they leave the basal layer.
However, in infected cells, expression of the early viral oncoproteins E6 and E7 enables
these differentiating cells to remain active in the cell cycle. The E6 mainly interacts with
the tumor suppressor p53, resulting in ubiquitination and subsequent degradation of p53
through the recruitment of the ubiquitin ligase E6-AP (Huibregtse et al., 1991). p53
regulates the expression of proteins involved in cell cycle control, including the cyclin
kinase inhibitor p21 (Ko & Prives, 1996). When DNA damage occurs, p53 becomes
activated and induces expression of p21, leading to cell cycle arrest and apoptosis (Ko &
Prives, 1996). Via binding E6 to p53, HPV overcomes the proapoptotic activites of p53
and allows for cell cycle progression (Huibregtse et al., 1991). E7 also inactivates and
induces the degradation of retinoblastoma protein (pRB), a cell cycle regulatory protein
required for the G1/S transition and DNA synthesis (Cheng et al., 1995). The abrogation
of pRB allows productive viral replication in differentiated suprabasal cells (Chellappan
et al., 1992). In this manner, HPV maintains a productive, disseminating infection in the
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differentiated epithelial cells and establishes a reservoir of infection in the
undifferentiated basal cells. Like HPV, C. trachomatis may use nectin-1-induced
signaling to regulate productive and chronic genital infection. Investigating the
relationships between nectin-1 and other endogenous host factors may reveal unknown,
compelling aspects of chlamydia-host cell interaction.
At the present time, the major problem of the chlamydial research field is that
there is no workable genetic system for transformation and mutagenesis of the chlamydial
genome. Thus, it is not feasible to apply genetic approaches that are currently used for
other organisms. In addition, the obligate intracellular nature of these organisms makes
research on them even more challenging. However, previous persistence studies have led
to important findings in chlamydial biology and pathogenesis. For example, experiments
examining the effect of IFN-γ on chlamydial development have led to the identification
of an important underlying mechanism that helps control chlamydal infection in vivo.
Similarly, data from our tissue culture model of HSV-2/C. trachomatis co-infection have
potentially uncovered a novel host cellular response that limits chlamydial development.
Future investigations on the underlying mechanisms that drive developing chlamydiae to
enter persistence will provide detailed information of this anti-chlamydial pathway and
will allow us to evaluate its contribution to chlamydial pathogenesis and host defense in
vivo. Such investigations will also reveal new and compelling facets of chlamydia-host
cell interaction and will hasten development of in vivo models of polymicrobial sexually
transmitted infections.
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